[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fQOP6yGU4veUTkFm90sNuLb-w_UPy5ekyNd8hczusyTk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":78,"rows":85},"Indonesia University",[4],440,false,45,38,58257,13,296,[14,17,20,22,25,27,29,31],{"name":15,"count":16},"Obesity",10,{"name":18,"count":19},"Sepsis",7,{"name":21,"count":19},"Surgery",{"name":23,"count":24},"Acne Vulgaris",6,{"name":26,"count":24},"Quality of Life",{"name":28,"count":24},"Oxidative Stress",{"name":30,"count":24},"Anesthesia",{"name":32,"count":24},"Diabetes Mellitus",[34,39,44,49,54,59,64,68,73],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06781970","Effect of Vitamin C Supplementation in Corneal Endothelial Damage in Phacoemulsification of Patients with Hard Cataracts","2025-03","Oral Vitamin C",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT06720610","Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis","2025-04-25","Vonoprazan 20 mg",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT05550415","The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer","2025-05","Simvastatin 40mg",{"nctId":50,"briefTitle":51,"date":52,"intervention":53},"NCT06780644","Comparison of Effectiveness and Safety of Triple Combination Cream of Fucinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05% with Mometasone Furoate 0.1%, Hydroquinone 4%, Tretinoin 0.05% in the Treatment of Melasma","2025-05-26","Triple combination cream",{"nctId":55,"briefTitle":56,"date":57,"intervention":58},"NCT06903546","The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients","2025-06-30","Propolis drops",{"nctId":60,"briefTitle":61,"date":62,"intervention":63},"NCT07144241","Mesenchymal Stromal\u002FStem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients","2025-12-31","Mesenchymal Stromal\u002FStem Cells-Derived Exosomes (Exo-HWS + 1 vial Exo-HUVEC) Therapy",{"nctId":65,"briefTitle":66,"date":62,"intervention":67},"NCT07037992","The Effect of Quadratus Lumborum (QL) Block on the Incidence of Chronic Neuropathic Pain After Retroperitoneal Laparoscopic Donor Nephrectomy: A Study on Neuroinflammation and Neurophysiology","injection of local anesthesia solution",{"nctId":69,"briefTitle":70,"date":71,"intervention":72},"NCT06839651","Umbilical Cord Mesenchymal Stem Cell Secretome in Severe Erectile Dysfunction Non-responsive to Sildenafil","2026-04-01","uc-msc secretome intra cavernous",{"nctId":74,"briefTitle":75,"date":76,"intervention":77},"NCT07137130","Secretome TGF Beta 3","2026-05-14","Concentrated secretome Injection 3 mL",[79,80,81,82,83,84],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[86,126,149,167,202,225,243,263,286,304,324,347,371,389,455,507,546,578,618,655,681,699,726,744,770,796,822,840,858,876,903,921,950,968,996,1014,1032,1058,1082,1111,1129,1147,1174,1192,1217,1235,1262,1287,1305,1323,1341,1359,1377,1400,1428,1446,1464,1490,1515,1533,1551,1573,1607,1625,1648,1666,1695,1713,1742,1760,1785,1803,1827,1853,1871,1897,1921,1947,1965,1991,2009,2034,2059,2084,2110,2128,2154,2177,2195,2219,2237,2261,2279,2297,2319,2343,2370,2388,2406,2432,2450,2476,2494,2520,2544,2573,2591,2620,2653,2686,2709,2736,2754,2778,2803,2829,2847,2873,2891,2909,2927,2951,2977,2995,3020,3038,3063,3090,3115,3133,3151,3179,3204,3228,3251,3269,3295,3313,3337,3362,3389,3407,3433,3461,3479,3497,3522,3540,3565,3593,3611,3629,3647,3672,3690,3716,3734,3761,3779,3797,3822,3858,3890,3914,3940,3965,3983,4009,4027,4052,4077,4095,4120,4145,4163,4188,4206,4233,4251,4275,4299,4324,4352,4370,4388,4414,4432,4456,4481,4499,4525,4554,4572,4600,4623,4641,4666,4691,4709,4735,4760,4784,4809,4827,4851,4869,4899,4917,4935,4953,4971,4995,5018,5036,5061,5083,5107],{"intervention":87,"totalTrials":88,"cells":89},"Esomeprazole",2,{"EARLY_PHASE1":90,"PHASE1":93,"PHASE2":95,"PHASE3":97,"PHASE4":112,"NA":124},{"trials":91,"activeCount":92},[],0,{"trials":94,"activeCount":92},[],{"trials":96,"activeCount":92},[],{"trials":98,"activeCount":92},[99],{"nctId":100,"briefTitle":101,"status":102,"phases":103,"primaryCompletion":104,"completion":105,"start":106,"enrollment":107,"conditions":108,"interventions":110},"NCT07326904","Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease","COMPLETED",[82],"2024-10-10","2024-12-13","2024-09-23",145,[109],"Gastro Oesophageal Reflux Disease",[111,87],"Fexuprazan",{"trials":113,"activeCount":123,"soonestReadout":42},[114],{"nctId":40,"briefTitle":41,"status":115,"phases":116,"primaryCompletion":42,"completion":117,"start":118,"enrollment":119,"conditions":120,"interventions":122},"NOT_YET_RECRUITING",[83],"2025-06-27","2024-12-09",216,[121],"Erosive Esophagitis",[43,87],1,{"trials":125,"activeCount":92},[],{"intervention":58,"totalTrials":123,"cells":127},{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":134,"PHASE4":136,"NA":147},{"trials":129,"activeCount":92},[],{"trials":131,"activeCount":92},[],{"trials":133,"activeCount":92},[],{"trials":135,"activeCount":92},[],{"trials":137,"activeCount":123,"soonestReadout":57},[138],{"nctId":55,"briefTitle":56,"status":139,"phases":140,"primaryCompletion":57,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":146},"RECRUITING",[83],"2025-07-31","2025-03-18",64,[145],"Diabetes Mellitus Type 2",[58],{"trials":148,"activeCount":92},[],{"intervention":43,"totalTrials":123,"cells":150},{"EARLY_PHASE1":151,"PHASE1":153,"PHASE2":155,"PHASE3":157,"PHASE4":159,"NA":165},{"trials":152,"activeCount":92},[],{"trials":154,"activeCount":92},[],{"trials":156,"activeCount":92},[],{"trials":158,"activeCount":92},[],{"trials":160,"activeCount":123,"soonestReadout":42},[161],{"nctId":40,"briefTitle":41,"status":115,"phases":162,"primaryCompletion":42,"completion":117,"start":118,"enrollment":119,"conditions":163,"interventions":164},[83],[121],[43,87],{"trials":166,"activeCount":92},[],{"intervention":48,"totalTrials":88,"cells":168},{"EARLY_PHASE1":169,"PHASE1":171,"PHASE2":173,"PHASE3":196,"PHASE4":198,"NA":200},{"trials":170,"activeCount":92},[],{"trials":172,"activeCount":92},[],{"trials":174,"activeCount":123,"soonestReadout":47},[175,187],{"nctId":176,"briefTitle":177,"status":102,"phases":178,"primaryCompletion":179,"completion":180,"start":181,"enrollment":182,"conditions":183,"interventions":186},"NCT04418089","Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer",[81],"2019-05-20","2019-09-05","2018-01-15",60,[184,185],"Breast Cancer","Chemotherapy Effect",[48],{"nctId":45,"briefTitle":46,"status":139,"phases":188,"primaryCompletion":47,"completion":189,"start":190,"enrollment":191,"conditions":192,"interventions":195},[81],"2025-08","2022-08-19",26,[193,185,194],"Triple Negative Breast Cancer","Simvastatin Adverse Reaction",[48],{"trials":197,"activeCount":92},[],{"trials":199,"activeCount":92},[],{"trials":201,"activeCount":92},[],{"intervention":63,"totalTrials":123,"cells":203},{"EARLY_PHASE1":204,"PHASE1":206,"PHASE2":208,"PHASE3":219,"PHASE4":221,"NA":223},{"trials":205,"activeCount":92},[],{"trials":207,"activeCount":92},[],{"trials":209,"activeCount":123,"soonestReadout":62},[210],{"nctId":60,"briefTitle":61,"status":115,"phases":211,"primaryCompletion":62,"completion":212,"start":213,"enrollment":214,"conditions":215,"interventions":217},[81],"2026-07-01","2025-09-01",50,[216],"Type 2 Diabetes Mellitus",[63,218],"Mesenchymal Stromal\u002FStem Cells-Derived Exosomes (Exo-HWS ) Therapy",{"trials":220,"activeCount":92},[],{"trials":222,"activeCount":92},[],{"trials":224,"activeCount":92},[],{"intervention":218,"totalTrials":123,"cells":226},{"EARLY_PHASE1":227,"PHASE1":229,"PHASE2":231,"PHASE3":237,"PHASE4":239,"NA":241},{"trials":228,"activeCount":92},[],{"trials":230,"activeCount":92},[],{"trials":232,"activeCount":123,"soonestReadout":62},[233],{"nctId":60,"briefTitle":61,"status":115,"phases":234,"primaryCompletion":62,"completion":212,"start":213,"enrollment":214,"conditions":235,"interventions":236},[81],[216],[63,218],{"trials":238,"activeCount":92},[],{"trials":240,"activeCount":92},[],{"trials":242,"activeCount":92},[],{"intervention":72,"totalTrials":123,"cells":244},{"EARLY_PHASE1":245,"PHASE1":247,"PHASE2":255,"PHASE3":257,"PHASE4":259,"NA":261},{"trials":246,"activeCount":92},[],{"trials":248,"activeCount":123,"soonestReadout":71},[249],{"nctId":69,"briefTitle":70,"status":115,"phases":250,"primaryCompletion":71,"completion":71,"start":251,"enrollment":16,"conditions":252,"interventions":254},[80],"2025-04-21",[253],"Erectile Dysfunctions",[72],{"trials":256,"activeCount":92},[],{"trials":258,"activeCount":92},[],{"trials":260,"activeCount":92},[],{"trials":262,"activeCount":92},[],{"intervention":77,"totalTrials":123,"cells":264},{"EARLY_PHASE1":265,"PHASE1":267,"PHASE2":269,"PHASE3":271,"PHASE4":273,"NA":275},{"trials":266,"activeCount":92},[],{"trials":268,"activeCount":92},[],{"trials":270,"activeCount":92},[],{"trials":272,"activeCount":92},[],{"trials":274,"activeCount":92},[],{"trials":276,"activeCount":123,"soonestReadout":76},[277],{"nctId":74,"briefTitle":75,"status":115,"phases":278,"primaryCompletion":76,"completion":279,"start":280,"enrollment":281,"conditions":282,"interventions":284},[84],"2026-12-20","2026-02-14",34,[283],"Melasma",[77,285],"Concentrated secretome Injection 3 mL with addition of TGF Beta 3",{"intervention":285,"totalTrials":123,"cells":287},{"EARLY_PHASE1":288,"PHASE1":290,"PHASE2":292,"PHASE3":294,"PHASE4":296,"NA":298},{"trials":289,"activeCount":92},[],{"trials":291,"activeCount":92},[],{"trials":293,"activeCount":92},[],{"trials":295,"activeCount":92},[],{"trials":297,"activeCount":92},[],{"trials":299,"activeCount":123,"soonestReadout":76},[300],{"nctId":74,"briefTitle":75,"status":115,"phases":301,"primaryCompletion":76,"completion":279,"start":280,"enrollment":281,"conditions":302,"interventions":303},[84],[283],[77,285],{"intervention":53,"totalTrials":123,"cells":305},{"EARLY_PHASE1":306,"PHASE1":308,"PHASE2":310,"PHASE3":312,"PHASE4":314,"NA":316},{"trials":307,"activeCount":92},[],{"trials":309,"activeCount":92},[],{"trials":311,"activeCount":92},[],{"trials":313,"activeCount":92},[],{"trials":315,"activeCount":92},[],{"trials":317,"activeCount":123,"soonestReadout":52},[318],{"nctId":50,"briefTitle":51,"status":115,"phases":319,"primaryCompletion":52,"completion":213,"start":320,"enrollment":321,"conditions":322,"interventions":323},[84],"2025-02-17",56,[283],[53,53],{"intervention":38,"totalTrials":123,"cells":325},{"EARLY_PHASE1":326,"PHASE1":328,"PHASE2":330,"PHASE3":332,"PHASE4":334,"NA":336},{"trials":327,"activeCount":92},[],{"trials":329,"activeCount":92},[],{"trials":331,"activeCount":92},[],{"trials":333,"activeCount":92},[],{"trials":335,"activeCount":92},[],{"trials":337,"activeCount":123,"soonestReadout":37},[338],{"nctId":35,"briefTitle":36,"status":139,"phases":339,"primaryCompletion":37,"completion":340,"start":341,"enrollment":342,"conditions":343,"interventions":346},[84],"2025-06","2024-12-07",120,[344,345],"Endothelial Cell Loss, Corneal","Cataract and Intraocular Lens (IOL) Surgery",[38],{"intervention":67,"totalTrials":123,"cells":348},{"EARLY_PHASE1":349,"PHASE1":351,"PHASE2":353,"PHASE3":355,"PHASE4":357,"NA":359},{"trials":350,"activeCount":92},[],{"trials":352,"activeCount":92},[],{"trials":354,"activeCount":92},[],{"trials":356,"activeCount":92},[],{"trials":358,"activeCount":92},[],{"trials":360,"activeCount":123,"soonestReadout":62},[361],{"nctId":65,"briefTitle":66,"status":115,"phases":362,"primaryCompletion":62,"completion":62,"start":363,"enrollment":182,"conditions":364,"interventions":369},[84],"2025-07-01",[365,366,367,368],"Chronic Pain","Living Kidney Donor","Quadratus Lumborum Block","Laparoscopic Donor Nephrectomy",[67,370],"Injection of normal saline",{"intervention":370,"totalTrials":123,"cells":372},{"EARLY_PHASE1":373,"PHASE1":375,"PHASE2":377,"PHASE3":379,"PHASE4":381,"NA":383},{"trials":374,"activeCount":92},[],{"trials":376,"activeCount":92},[],{"trials":378,"activeCount":92},[],{"trials":380,"activeCount":92},[],{"trials":382,"activeCount":92},[],{"trials":384,"activeCount":123,"soonestReadout":62},[385],{"nctId":65,"briefTitle":66,"status":115,"phases":386,"primaryCompletion":62,"completion":62,"start":363,"enrollment":182,"conditions":387,"interventions":388},[84],[365,366,367,368],[67,370],{"intervention":390,"totalTrials":391,"cells":392},"Dexamethasone",4,{"EARLY_PHASE1":393,"PHASE1":395,"PHASE2":397,"PHASE3":399,"PHASE4":401,"NA":453},{"trials":394,"activeCount":92},[],{"trials":396,"activeCount":92},[],{"trials":398,"activeCount":92},[],{"trials":400,"activeCount":92},[],{"trials":402,"activeCount":92},[403,415,427,440],{"nctId":404,"briefTitle":405,"status":406,"phases":407,"primaryCompletion":408,"completion":409,"start":410,"enrollment":342,"conditions":411,"interventions":414},"NCT03366584","The Effect of β-Carotene, Vitamin D3 and Zinc on Hyaline Membrane Disease and Feeding Intolerance in Premature Neonates","UNKNOWN",[83],"2018-12","2019-06","2017-01",[412,413],"Hyaline Membrane Disease","Necrotizing Enterocolitis of Newborn",[390],{"nctId":416,"briefTitle":417,"status":102,"phases":418,"primaryCompletion":419,"completion":420,"start":421,"enrollment":342,"conditions":422,"interventions":425},"NCT05487508","Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients",[83],"2019-01-31","2019-03-31","2018-07-01",[423,424],"Coronary Artery Disease","Inflammatory Response",[390,426],"Normal saline",{"nctId":428,"briefTitle":429,"status":102,"phases":430,"primaryCompletion":431,"completion":432,"start":433,"enrollment":434,"conditions":435,"interventions":438},"NCT05246631","Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy",[83],"2020-03-30","2020-07-30","2020-01-01",80,[436,437],"Laparoscopy","Postoperative Nausea and Vomiting",[390,439],"Haloperidol",{"nctId":441,"briefTitle":442,"status":102,"phases":443,"primaryCompletion":444,"completion":445,"start":410,"enrollment":321,"conditions":446,"interventions":448},"NCT03005496","The Effect of Zinc, β-carotene, and Vitamin D3 in Preterm Delivery Through Placental MyD88, TRIF, NFkB, and IL-1β",[83],"2017-04","2017-06",[447],"PreTerm Birth",[449,450,451,452,390],"Zinc","Nifedipine","Beta Carotene","Vitamin D3",{"trials":454,"activeCount":92},[],{"intervention":456,"totalTrials":457,"cells":458},"Dexmedetomidine",3,{"EARLY_PHASE1":459,"PHASE1":461,"PHASE2":463,"PHASE3":465,"PHASE4":492,"NA":505},{"trials":460,"activeCount":92},[],{"trials":462,"activeCount":92},[],{"trials":464,"activeCount":92},[],{"trials":466,"activeCount":92},[467,480],{"nctId":468,"briefTitle":469,"status":102,"phases":470,"primaryCompletion":471,"completion":472,"start":473,"enrollment":474,"conditions":475,"interventions":478},"NCT06394375","Opioid Free Anesthesia in Abdominal Laparoscopic Surgery",[81,82],"2023-10-31","2023-12-31","2023-07-01",74,[476,477],"Laparoscopic Surgery","Abdominal Surgery",[456,479],"Fentanyl",{"nctId":481,"briefTitle":482,"status":406,"phases":483,"primaryCompletion":484,"completion":485,"start":486,"enrollment":487,"conditions":488,"interventions":491},"NCT06382831","Opioid Free Versus Opioid Balanced Anesthesia in Ophthalmic Surgery",[81,82],"2024-08-01","2024-10-01","2024-06-01",104,[489,490],"Anesthesia and Analgesia","Anesthesia, Endotracheal",[456,479],{"trials":493,"activeCount":92},[494],{"nctId":495,"briefTitle":496,"status":102,"phases":497,"primaryCompletion":498,"completion":499,"start":500,"enrollment":143,"conditions":501,"interventions":503},"NCT07544173","Intravenous Magnesium Sulphate Versus Dexmedetomidine for Prevention of Emergence Agitation in Adult Otorhinolaryngologic Surgery",[83],"2024-08-31","2025-01-01","2024-05-01",[502],"Adults Undergoing Otorhinolaryngology Surgery",[504,456],"Magnesium sulphate",{"trials":506,"activeCount":92},[],{"intervention":508,"totalTrials":88,"cells":509},"Alfacalcidol",{"EARLY_PHASE1":510,"PHASE1":512,"PHASE2":514,"PHASE3":516,"PHASE4":530,"NA":544},{"trials":511,"activeCount":92},[],{"trials":513,"activeCount":92},[],{"trials":515,"activeCount":92},[],{"trials":517,"activeCount":92},[518],{"nctId":519,"briefTitle":520,"status":102,"phases":521,"primaryCompletion":522,"completion":523,"start":524,"enrollment":525,"conditions":526,"interventions":528},"NCT02327091","The Effect of Alfacalcidol on Muscle Strength in Elderly Indonesian Women : A Randomized Controlled Trial",[82],"2012-09","2012-12","2012-04",122,[527],"Muscle Weakness",[529],"alfacalcidol",{"trials":531,"activeCount":92},[532],{"nctId":533,"briefTitle":534,"status":406,"phases":535,"primaryCompletion":536,"completion":537,"start":538,"enrollment":539,"conditions":540,"interventions":543},"NCT03292744","Effect of Alfacalcidol to Respiratory Infection and Immune Response of Indonesian Elderly",[83],"2017-10-10","2017-12-15","2017-01-10",110,[541,542],"Frail Elderly Syndrome","Elderly Infection",[508],{"trials":545,"activeCount":92},[],{"intervention":426,"totalTrials":88,"cells":547},{"EARLY_PHASE1":548,"PHASE1":550,"PHASE2":552,"PHASE3":554,"PHASE4":556,"NA":576},{"trials":549,"activeCount":92},[],{"trials":551,"activeCount":92},[],{"trials":553,"activeCount":92},[],{"trials":555,"activeCount":92},[],{"trials":557,"activeCount":92},[558,562],{"nctId":416,"briefTitle":417,"status":102,"phases":559,"primaryCompletion":419,"completion":420,"start":421,"enrollment":342,"conditions":560,"interventions":561},[83],[423,424],[390,426],{"nctId":563,"briefTitle":564,"status":102,"phases":565,"primaryCompletion":566,"completion":567,"start":568,"enrollment":569,"conditions":570,"interventions":573},"NCT05708690","Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery",[83],"2022-12-31","2023-01-06","2022-10-01",132,[423,571,572],"Valvular Heart Disease","Surgical Blood Loss",[574,575],"Tranexamic Acid 100 MG\u002FML","normal saline",{"trials":577,"activeCount":92},[],{"intervention":579,"totalTrials":88,"cells":580},"Intranasal dexmedetomidine",{"EARLY_PHASE1":581,"PHASE1":583,"PHASE2":585,"PHASE3":587,"PHASE4":603,"NA":616},{"trials":582,"activeCount":92},[],{"trials":584,"activeCount":92},[],{"trials":586,"activeCount":92},[],{"trials":588,"activeCount":92},[589],{"nctId":590,"briefTitle":591,"status":102,"phases":592,"primaryCompletion":593,"completion":594,"start":595,"enrollment":596,"conditions":597,"interventions":601},"NCT06991647","Effectiveness of Intranasal Dexmedetomidine Premedication in Child Intubation",[82],"2024-12-28","2025-01-10","2024-10-28",40,[598,599,600],"Elective Surgical Procedure","ASA Physical Status I","ASA Physical Status II",[579,602],"0.9% NaCl solution",{"trials":604,"activeCount":92},[605],{"nctId":606,"briefTitle":607,"status":102,"phases":608,"primaryCompletion":609,"completion":609,"start":610,"enrollment":611,"conditions":612,"interventions":614},"NCT04263844","Intranasal Dexmedetomidine Versus Intranasal Midazolam for Emergence Delirium Prevention",[83],"2019-10-10","2019-01-10",66,[613],"Emergence Delirium",[579,615],"Intranasal Midazolam",{"trials":617,"activeCount":92},[],{"intervention":619,"totalTrials":88,"cells":620},"dihydroartemisinin-piperaquine",{"EARLY_PHASE1":621,"PHASE1":623,"PHASE2":625,"PHASE3":627,"PHASE4":629,"NA":653},{"trials":622,"activeCount":92},[],{"trials":624,"activeCount":92},[],{"trials":626,"activeCount":92},[],{"trials":628,"activeCount":92},[],{"trials":630,"activeCount":92},[631,643],{"nctId":632,"briefTitle":633,"status":102,"phases":634,"primaryCompletion":635,"completion":636,"start":637,"enrollment":638,"conditions":639,"interventions":641},"NCT01392014","Dihydroartemisinin-piperaquine and Primaquine for Uncomplicated Plasmodium Falciparum Cases",[83],"2010-03","2010-10","2008-12",374,[640],"Malaria",[619,642],"dihydroartemisinin-piperaquine + primaquine",{"nctId":644,"briefTitle":645,"status":102,"phases":646,"primaryCompletion":647,"completion":647,"start":648,"enrollment":649,"conditions":650,"interventions":651},"NCT01878357","Surveillance and Treatment With Dihydroartemisinin-piperaquine Plus Primaquine",[83],"2013-11","2013-06",1488,[640],[619,652],"primaquine",{"trials":654,"activeCount":92},[],{"intervention":656,"totalTrials":123,"cells":657},"Ketoprofen 100mg",{"EARLY_PHASE1":658,"PHASE1":660,"PHASE2":662,"PHASE3":664,"PHASE4":666,"NA":679},{"trials":659,"activeCount":92},[],{"trials":661,"activeCount":92},[],{"trials":663,"activeCount":92},[],{"trials":665,"activeCount":92},[],{"trials":667,"activeCount":92},[668],{"nctId":669,"briefTitle":670,"status":102,"phases":671,"primaryCompletion":672,"completion":673,"start":674,"enrollment":182,"conditions":675,"interventions":677},"NCT07315698","Efficacy of Oral Paracetamol Compared With Oral Ketoprofen for Pain Management in Office Hysteroscopy",[83],"2023-05-30","2025-08-22","2020-11-01",[676],"Office Hysteroscopy",[656,678],"Paracetamol 1000 Mg Oral",{"trials":680,"activeCount":92},[],{"intervention":678,"totalTrials":123,"cells":682},{"EARLY_PHASE1":683,"PHASE1":685,"PHASE2":687,"PHASE3":689,"PHASE4":691,"NA":697},{"trials":684,"activeCount":92},[],{"trials":686,"activeCount":92},[],{"trials":688,"activeCount":92},[],{"trials":690,"activeCount":92},[],{"trials":692,"activeCount":92},[693],{"nctId":669,"briefTitle":670,"status":102,"phases":694,"primaryCompletion":672,"completion":673,"start":674,"enrollment":182,"conditions":695,"interventions":696},[83],[676],[656,678],{"trials":698,"activeCount":92},[],{"intervention":700,"totalTrials":123,"cells":701},"Platelet-Rich Plasma and Topical 5% Minoxidil",{"EARLY_PHASE1":702,"PHASE1":704,"PHASE2":706,"PHASE3":708,"PHASE4":710,"NA":724},{"trials":703,"activeCount":92},[],{"trials":705,"activeCount":92},[],{"trials":707,"activeCount":92},[],{"trials":709,"activeCount":92},[],{"trials":711,"activeCount":92},[712],{"nctId":713,"briefTitle":714,"status":406,"phases":715,"primaryCompletion":716,"completion":717,"start":718,"enrollment":719,"conditions":720,"interventions":722},"NCT06043349","Effectiveness and Safety of Platelet-rich Plasma and Topical 5% Minoxidil Combination in Male Androgenetic Alopecia",[83],"2023-09-01","2023-09-30","2023-06-01",36,[721],"Androgenetic Alopecia",[700,723],"Topical 5% Minoxidil",{"trials":725,"activeCount":92},[],{"intervention":723,"totalTrials":123,"cells":727},{"EARLY_PHASE1":728,"PHASE1":730,"PHASE2":732,"PHASE3":734,"PHASE4":736,"NA":742},{"trials":729,"activeCount":92},[],{"trials":731,"activeCount":92},[],{"trials":733,"activeCount":92},[],{"trials":735,"activeCount":92},[],{"trials":737,"activeCount":92},[738],{"nctId":713,"briefTitle":714,"status":406,"phases":739,"primaryCompletion":716,"completion":717,"start":718,"enrollment":719,"conditions":740,"interventions":741},[83],[721],[700,723],{"trials":743,"activeCount":92},[],{"intervention":745,"totalTrials":123,"cells":746},"Flubio",{"EARLY_PHASE1":747,"PHASE1":749,"PHASE2":751,"PHASE3":753,"PHASE4":755,"NA":768},{"trials":748,"activeCount":92},[],{"trials":750,"activeCount":92},[],{"trials":752,"activeCount":92},[],{"trials":754,"activeCount":92},[],{"trials":756,"activeCount":92},[757],{"nctId":758,"briefTitle":759,"status":102,"phases":760,"primaryCompletion":761,"completion":762,"start":763,"enrollment":764,"conditions":765,"interventions":767},"NCT03695432","Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in Elderly",[83],"2015-04","2016-07","2014-10",910,[766],"Influenza-like Illness",[745],{"trials":769,"activeCount":92},[],{"intervention":771,"totalTrials":123,"cells":772},"Aflibercept Injection [Eylea]",{"EARLY_PHASE1":773,"PHASE1":775,"PHASE2":777,"PHASE3":779,"PHASE4":781,"NA":794},{"trials":774,"activeCount":92},[],{"trials":776,"activeCount":92},[],{"trials":778,"activeCount":92},[],{"trials":780,"activeCount":92},[],{"trials":782,"activeCount":92},[783],{"nctId":784,"briefTitle":785,"status":102,"phases":786,"primaryCompletion":787,"completion":788,"start":536,"enrollment":719,"conditions":789,"interventions":793},"NCT03453281","Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection",[83],"2018-04-09","2018-05-18",[790,791,792],"Diabetic Macular Edema","Diabetic Retinopathy","Clinically Significant Macular Edema",[771],{"trials":795,"activeCount":92},[],{"intervention":797,"totalTrials":123,"cells":798},"self-manufactured 40% dextrose gel",{"EARLY_PHASE1":799,"PHASE1":801,"PHASE2":803,"PHASE3":805,"PHASE4":807,"NA":820},{"trials":800,"activeCount":92},[],{"trials":802,"activeCount":92},[],{"trials":804,"activeCount":92},[],{"trials":806,"activeCount":92},[],{"trials":808,"activeCount":92},[809],{"nctId":810,"briefTitle":811,"status":102,"phases":812,"primaryCompletion":813,"completion":813,"start":814,"enrollment":815,"conditions":816,"interventions":818},"NCT07015450","The Efficacy of Self-Manufactured 40% Dextrose Gel in Asymptomatic Transient Neonatal Hypoglycemia Treatment",[83],"2023-08-31","2023-05-01",133,[817],"Neonatal Hypoglycemia",[797,819],"Standard therapy",{"trials":821,"activeCount":92},[],{"intervention":819,"totalTrials":123,"cells":823},{"EARLY_PHASE1":824,"PHASE1":826,"PHASE2":828,"PHASE3":830,"PHASE4":832,"NA":838},{"trials":825,"activeCount":92},[],{"trials":827,"activeCount":92},[],{"trials":829,"activeCount":92},[],{"trials":831,"activeCount":92},[],{"trials":833,"activeCount":92},[834],{"nctId":810,"briefTitle":811,"status":102,"phases":835,"primaryCompletion":813,"completion":813,"start":814,"enrollment":815,"conditions":836,"interventions":837},[83],[817],[797,819],{"trials":839,"activeCount":92},[],{"intervention":574,"totalTrials":123,"cells":841},{"EARLY_PHASE1":842,"PHASE1":844,"PHASE2":846,"PHASE3":848,"PHASE4":850,"NA":856},{"trials":843,"activeCount":92},[],{"trials":845,"activeCount":92},[],{"trials":847,"activeCount":92},[],{"trials":849,"activeCount":92},[],{"trials":851,"activeCount":92},[852],{"nctId":563,"briefTitle":564,"status":102,"phases":853,"primaryCompletion":566,"completion":567,"start":568,"enrollment":569,"conditions":854,"interventions":855},[83],[423,571,572],[574,575],{"trials":857,"activeCount":92},[],{"intervention":642,"totalTrials":123,"cells":859},{"EARLY_PHASE1":860,"PHASE1":862,"PHASE2":864,"PHASE3":866,"PHASE4":868,"NA":874},{"trials":861,"activeCount":92},[],{"trials":863,"activeCount":92},[],{"trials":865,"activeCount":92},[],{"trials":867,"activeCount":92},[],{"trials":869,"activeCount":92},[870],{"nctId":632,"briefTitle":633,"status":102,"phases":871,"primaryCompletion":635,"completion":636,"start":637,"enrollment":638,"conditions":872,"interventions":873},[83],[640],[619,642],{"trials":875,"activeCount":92},[],{"intervention":877,"totalTrials":123,"cells":878},"Nepafenac 0.1% eyedrops",{"EARLY_PHASE1":879,"PHASE1":881,"PHASE2":883,"PHASE3":885,"PHASE4":887,"NA":901},{"trials":880,"activeCount":92},[],{"trials":882,"activeCount":92},[],{"trials":884,"activeCount":92},[],{"trials":886,"activeCount":92},[],{"trials":888,"activeCount":92},[889],{"nctId":890,"briefTitle":891,"status":102,"phases":892,"primaryCompletion":893,"completion":893,"start":894,"enrollment":895,"conditions":896,"interventions":899},"NCT07162818","Effects of 0.1% Nepafenac on Vitreous Inflammatory Biomarkers in Rhegmatogenous Retinal Detachment and Proliferative Vitreoretinopathy",[83],"2021-12-01","2021-04-28",61,[897,898],"Proliferative Vitreoretinopathy","Rhegmatogenous Retinal Detachment",[877,900],"Control (placebo) group",{"trials":902,"activeCount":92},[],{"intervention":900,"totalTrials":123,"cells":904},{"EARLY_PHASE1":905,"PHASE1":907,"PHASE2":909,"PHASE3":911,"PHASE4":913,"NA":919},{"trials":906,"activeCount":92},[],{"trials":908,"activeCount":92},[],{"trials":910,"activeCount":92},[],{"trials":912,"activeCount":92},[],{"trials":914,"activeCount":92},[915],{"nctId":890,"briefTitle":891,"status":102,"phases":916,"primaryCompletion":893,"completion":893,"start":894,"enrollment":895,"conditions":917,"interventions":918},[83],[897,898],[877,900],{"trials":920,"activeCount":92},[],{"intervention":922,"totalTrials":123,"cells":923},"Ceftazidime",{"EARLY_PHASE1":924,"PHASE1":926,"PHASE2":928,"PHASE3":930,"PHASE4":932,"NA":948},{"trials":925,"activeCount":92},[],{"trials":927,"activeCount":92},[],{"trials":929,"activeCount":92},[],{"trials":931,"activeCount":92},[],{"trials":933,"activeCount":92},[934],{"nctId":935,"briefTitle":936,"status":102,"phases":937,"primaryCompletion":938,"completion":938,"start":939,"enrollment":940,"conditions":941,"interventions":946},"NCT04187755","Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever",[83],"2019-07-31","2019-03-01",72,[942,943,944,945],"Neutropenia, Febrile","Leukemia","Pediatric Cancer","Antibiotic Reaction",[922,947],"Cefepime",{"trials":949,"activeCount":92},[],{"intervention":947,"totalTrials":123,"cells":951},{"EARLY_PHASE1":952,"PHASE1":954,"PHASE2":956,"PHASE3":958,"PHASE4":960,"NA":966},{"trials":953,"activeCount":92},[],{"trials":955,"activeCount":92},[],{"trials":957,"activeCount":92},[],{"trials":959,"activeCount":92},[],{"trials":961,"activeCount":92},[962],{"nctId":935,"briefTitle":936,"status":102,"phases":963,"primaryCompletion":938,"completion":938,"start":939,"enrollment":940,"conditions":964,"interventions":965},[83],[942,943,944,945],[922,947],{"trials":967,"activeCount":92},[],{"intervention":969,"totalTrials":123,"cells":970},"combination oral and topical vitamin D",{"EARLY_PHASE1":971,"PHASE1":973,"PHASE2":975,"PHASE3":977,"PHASE4":979,"NA":994},{"trials":972,"activeCount":92},[],{"trials":974,"activeCount":92},[],{"trials":976,"activeCount":92},[],{"trials":978,"activeCount":92},[],{"trials":980,"activeCount":92},[981],{"nctId":982,"briefTitle":983,"status":406,"phases":984,"primaryCompletion":985,"completion":986,"start":987,"enrollment":988,"conditions":989,"interventions":991},"NCT05758259","The Efficacy and Safety of Topical Vitamin D and Supplementation In Acne Vulgaris The Study of VDR, IL-1β, IL-6, IL-10 and IL-17 Expression",[83],"2023-08","2023-10","2023-02-16",105,[23,990],"Vitamin D",[969,992,993],"oral placebo and topical cholecalciferol","oral placebo and basic ingredient placebo topical vitamin D",{"trials":995,"activeCount":92},[],{"intervention":992,"totalTrials":123,"cells":997},{"EARLY_PHASE1":998,"PHASE1":1000,"PHASE2":1002,"PHASE3":1004,"PHASE4":1006,"NA":1012},{"trials":999,"activeCount":92},[],{"trials":1001,"activeCount":92},[],{"trials":1003,"activeCount":92},[],{"trials":1005,"activeCount":92},[],{"trials":1007,"activeCount":92},[1008],{"nctId":982,"briefTitle":983,"status":406,"phases":1009,"primaryCompletion":985,"completion":986,"start":987,"enrollment":988,"conditions":1010,"interventions":1011},[83],[23,990],[969,992,993],{"trials":1013,"activeCount":92},[],{"intervention":993,"totalTrials":123,"cells":1015},{"EARLY_PHASE1":1016,"PHASE1":1018,"PHASE2":1020,"PHASE3":1022,"PHASE4":1024,"NA":1030},{"trials":1017,"activeCount":92},[],{"trials":1019,"activeCount":92},[],{"trials":1021,"activeCount":92},[],{"trials":1023,"activeCount":92},[],{"trials":1025,"activeCount":92},[1026],{"nctId":982,"briefTitle":983,"status":406,"phases":1027,"primaryCompletion":985,"completion":986,"start":987,"enrollment":988,"conditions":1028,"interventions":1029},[83],[23,990],[969,992,993],{"trials":1031,"activeCount":92},[],{"intervention":1033,"totalTrials":123,"cells":1034},"Vitamin E 400 UNT",{"EARLY_PHASE1":1035,"PHASE1":1037,"PHASE2":1039,"PHASE3":1041,"PHASE4":1043,"NA":1056},{"trials":1036,"activeCount":92},[],{"trials":1038,"activeCount":92},[],{"trials":1040,"activeCount":92},[],{"trials":1042,"activeCount":92},[],{"trials":1044,"activeCount":92},[1045],{"nctId":1046,"briefTitle":1047,"status":102,"phases":1048,"primaryCompletion":1049,"completion":1050,"start":1051,"enrollment":1052,"conditions":1053,"interventions":1055},"NCT03358524","Effects of Vitamin E Supplementation on Free Radicals and Fat Level of Obese Adolescence in Jakarta, Indonesia",[83],"2018-02-20","2018-03-01","2017-09-28",69,[1054,28],"Obesity, Adolescent",[1033],{"trials":1057,"activeCount":92},[],{"intervention":1059,"totalTrials":123,"cells":1060},"Ezerra cream",{"EARLY_PHASE1":1061,"PHASE1":1063,"PHASE2":1065,"PHASE3":1067,"PHASE4":1069,"NA":1080},{"trials":1062,"activeCount":92},[],{"trials":1064,"activeCount":92},[],{"trials":1066,"activeCount":92},[],{"trials":1068,"activeCount":92},[],{"trials":1070,"activeCount":92},[1071],{"nctId":1072,"briefTitle":1073,"status":102,"phases":1074,"primaryCompletion":672,"completion":1075,"start":814,"enrollment":1076,"conditions":1077,"interventions":1079},"NCT06255431","EFFECTIVENESS AND SAFETY OF CREAM CONTAINING SPENT GRAIN WAX EXTRACT, ARGAN OIL, AND SHEA BUTTER POST-TRICHOLOROACETIC ACID 15% PEEL: RANDOMIZED, CONTROLLED, DOUBLE-BLIND, SPLIT-FACE CLINICAL TRIAL",[83],"2023-06-04",27,[1078],"Aging Disorder",[1059],{"trials":1081,"activeCount":92},[],{"intervention":1083,"totalTrials":123,"cells":1084},"Centella Asiatica Extract",{"EARLY_PHASE1":1085,"PHASE1":1087,"PHASE2":1089,"PHASE3":1091,"PHASE4":1093,"NA":1109},{"trials":1086,"activeCount":92},[],{"trials":1088,"activeCount":92},[],{"trials":1090,"activeCount":92},[],{"trials":1092,"activeCount":92},[],{"trials":1094,"activeCount":92},[1095],{"nctId":1096,"briefTitle":1097,"status":406,"phases":1098,"primaryCompletion":1099,"completion":1100,"start":1101,"enrollment":1102,"conditions":1103,"interventions":1106},"NCT03815305","Effect of Centella Asiatica on Xerotic Skin in Diabetes Mellitus Type 2",[83],"2019-01-12","2019-06-30","2018-07-30",159,[1104,1105],"Xerosis Cutis","Diabetes Mellitus, Type 2",[1083,1107,1108],"Topical CA","Petroleum jelly",{"trials":1110,"activeCount":92},[],{"intervention":1107,"totalTrials":123,"cells":1112},{"EARLY_PHASE1":1113,"PHASE1":1115,"PHASE2":1117,"PHASE3":1119,"PHASE4":1121,"NA":1127},{"trials":1114,"activeCount":92},[],{"trials":1116,"activeCount":92},[],{"trials":1118,"activeCount":92},[],{"trials":1120,"activeCount":92},[],{"trials":1122,"activeCount":92},[1123],{"nctId":1096,"briefTitle":1097,"status":406,"phases":1124,"primaryCompletion":1099,"completion":1100,"start":1101,"enrollment":1102,"conditions":1125,"interventions":1126},[83],[1104,1105],[1083,1107,1108],{"trials":1128,"activeCount":92},[],{"intervention":1108,"totalTrials":123,"cells":1130},{"EARLY_PHASE1":1131,"PHASE1":1133,"PHASE2":1135,"PHASE3":1137,"PHASE4":1139,"NA":1145},{"trials":1132,"activeCount":92},[],{"trials":1134,"activeCount":92},[],{"trials":1136,"activeCount":92},[],{"trials":1138,"activeCount":92},[],{"trials":1140,"activeCount":92},[1141],{"nctId":1096,"briefTitle":1097,"status":406,"phases":1142,"primaryCompletion":1099,"completion":1100,"start":1101,"enrollment":1102,"conditions":1143,"interventions":1144},[83],[1104,1105],[1083,1107,1108],{"trials":1146,"activeCount":92},[],{"intervention":1148,"totalTrials":123,"cells":1149},"Paracetamol",{"EARLY_PHASE1":1150,"PHASE1":1152,"PHASE2":1154,"PHASE3":1156,"PHASE4":1158,"NA":1172},{"trials":1151,"activeCount":92},[],{"trials":1153,"activeCount":92},[],{"trials":1155,"activeCount":92},[],{"trials":1157,"activeCount":92},[],{"trials":1159,"activeCount":92},[1160],{"nctId":1161,"briefTitle":1162,"status":102,"phases":1163,"primaryCompletion":1164,"completion":1165,"start":1166,"enrollment":1167,"conditions":1168,"interventions":1170},"NCT05523102","Paracetamol Compared With Ketorolac for Post-operative Analgetic",[83],"2022-07-18","2022-08-02","2022-03-31",85,[1169],"Pain, Postoperative",[1148,1171],"Ketorolac",{"trials":1173,"activeCount":92},[],{"intervention":1171,"totalTrials":123,"cells":1175},{"EARLY_PHASE1":1176,"PHASE1":1178,"PHASE2":1180,"PHASE3":1182,"PHASE4":1184,"NA":1190},{"trials":1177,"activeCount":92},[],{"trials":1179,"activeCount":92},[],{"trials":1181,"activeCount":92},[],{"trials":1183,"activeCount":92},[],{"trials":1185,"activeCount":92},[1186],{"nctId":1161,"briefTitle":1162,"status":102,"phases":1187,"primaryCompletion":1164,"completion":1165,"start":1166,"enrollment":1167,"conditions":1188,"interventions":1189},[83],[1169],[1148,1171],{"trials":1191,"activeCount":92},[],{"intervention":1193,"totalTrials":123,"cells":1194},"MgSO4",{"EARLY_PHASE1":1195,"PHASE1":1197,"PHASE2":1199,"PHASE3":1201,"PHASE4":1203,"NA":1215},{"trials":1196,"activeCount":92},[],{"trials":1198,"activeCount":92},[],{"trials":1200,"activeCount":92},[],{"trials":1202,"activeCount":92},[],{"trials":1204,"activeCount":92},[1205],{"nctId":1206,"briefTitle":1207,"status":102,"phases":1208,"primaryCompletion":568,"completion":1209,"start":1210,"enrollment":1211,"conditions":1212,"interventions":1214},"NCT05609955","Effects Of Additional MgSO4 30 Mg\u002FKgBW Intravenous and Ketorolac",[83],"2022-11-01","2022-01-01",48,[30,1169,21,1213],"Opioid Use",[1193],{"trials":1216,"activeCount":92},[],{"intervention":439,"totalTrials":123,"cells":1218},{"EARLY_PHASE1":1219,"PHASE1":1221,"PHASE2":1223,"PHASE3":1225,"PHASE4":1227,"NA":1233},{"trials":1220,"activeCount":92},[],{"trials":1222,"activeCount":92},[],{"trials":1224,"activeCount":92},[],{"trials":1226,"activeCount":92},[],{"trials":1228,"activeCount":92},[1229],{"nctId":428,"briefTitle":429,"status":102,"phases":1230,"primaryCompletion":431,"completion":432,"start":433,"enrollment":434,"conditions":1231,"interventions":1232},[83],[436,437],[390,439],{"trials":1234,"activeCount":92},[],{"intervention":1236,"totalTrials":123,"cells":1237},"Azithromycin Powder",{"EARLY_PHASE1":1238,"PHASE1":1240,"PHASE2":1242,"PHASE3":1244,"PHASE4":1246,"NA":1260},{"trials":1239,"activeCount":92},[],{"trials":1241,"activeCount":92},[],{"trials":1243,"activeCount":92},[],{"trials":1245,"activeCount":92},[],{"trials":1247,"activeCount":92},[1248],{"nctId":1249,"briefTitle":1250,"status":102,"phases":1251,"primaryCompletion":1252,"completion":1253,"start":1254,"enrollment":342,"conditions":1255,"interventions":1259},"NCT05311228","The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm Infant",[83],"2022-03-01","2022-04-01","2021-06-08",[1256,1257,1258],"Bronchopulmonary Dysplasia","Intraventricular Hemorrhage","Necrotizing Enterocolitis",[1236],{"trials":1261,"activeCount":92},[],{"intervention":1263,"totalTrials":123,"cells":1264},"Dihydroartemisinin-piperaquine with primaquine",{"EARLY_PHASE1":1265,"PHASE1":1267,"PHASE2":1269,"PHASE3":1271,"PHASE4":1273,"NA":1285},{"trials":1266,"activeCount":92},[],{"trials":1268,"activeCount":92},[],{"trials":1270,"activeCount":92},[],{"trials":1272,"activeCount":92},[],{"trials":1274,"activeCount":92},[1275],{"nctId":1276,"briefTitle":1277,"status":102,"phases":1278,"primaryCompletion":1279,"completion":1280,"start":1281,"enrollment":1282,"conditions":1283,"interventions":1284},"NCT01389557","Impact of Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in Lampung Province, Sumatra",[83],"2011-11","2011-12","2011-02",77,[640],[1263],{"trials":1286,"activeCount":92},[],{"intervention":652,"totalTrials":123,"cells":1288},{"EARLY_PHASE1":1289,"PHASE1":1291,"PHASE2":1293,"PHASE3":1295,"PHASE4":1297,"NA":1303},{"trials":1290,"activeCount":92},[],{"trials":1292,"activeCount":92},[],{"trials":1294,"activeCount":92},[],{"trials":1296,"activeCount":92},[],{"trials":1298,"activeCount":92},[1299],{"nctId":644,"briefTitle":645,"status":102,"phases":1300,"primaryCompletion":647,"completion":647,"start":648,"enrollment":649,"conditions":1301,"interventions":1302},[83],[640],[619,652],{"trials":1304,"activeCount":92},[],{"intervention":449,"totalTrials":123,"cells":1306},{"EARLY_PHASE1":1307,"PHASE1":1309,"PHASE2":1311,"PHASE3":1313,"PHASE4":1315,"NA":1321},{"trials":1308,"activeCount":92},[],{"trials":1310,"activeCount":92},[],{"trials":1312,"activeCount":92},[],{"trials":1314,"activeCount":92},[],{"trials":1316,"activeCount":92},[1317],{"nctId":441,"briefTitle":442,"status":102,"phases":1318,"primaryCompletion":444,"completion":445,"start":410,"enrollment":321,"conditions":1319,"interventions":1320},[83],[447],[449,450,451,452,390],{"trials":1322,"activeCount":92},[],{"intervention":450,"totalTrials":123,"cells":1324},{"EARLY_PHASE1":1325,"PHASE1":1327,"PHASE2":1329,"PHASE3":1331,"PHASE4":1333,"NA":1339},{"trials":1326,"activeCount":92},[],{"trials":1328,"activeCount":92},[],{"trials":1330,"activeCount":92},[],{"trials":1332,"activeCount":92},[],{"trials":1334,"activeCount":92},[1335],{"nctId":441,"briefTitle":442,"status":102,"phases":1336,"primaryCompletion":444,"completion":445,"start":410,"enrollment":321,"conditions":1337,"interventions":1338},[83],[447],[449,450,451,452,390],{"trials":1340,"activeCount":92},[],{"intervention":451,"totalTrials":123,"cells":1342},{"EARLY_PHASE1":1343,"PHASE1":1345,"PHASE2":1347,"PHASE3":1349,"PHASE4":1351,"NA":1357},{"trials":1344,"activeCount":92},[],{"trials":1346,"activeCount":92},[],{"trials":1348,"activeCount":92},[],{"trials":1350,"activeCount":92},[],{"trials":1352,"activeCount":92},[1353],{"nctId":441,"briefTitle":442,"status":102,"phases":1354,"primaryCompletion":444,"completion":445,"start":410,"enrollment":321,"conditions":1355,"interventions":1356},[83],[447],[449,450,451,452,390],{"trials":1358,"activeCount":92},[],{"intervention":452,"totalTrials":123,"cells":1360},{"EARLY_PHASE1":1361,"PHASE1":1363,"PHASE2":1365,"PHASE3":1367,"PHASE4":1369,"NA":1375},{"trials":1362,"activeCount":92},[],{"trials":1364,"activeCount":92},[],{"trials":1366,"activeCount":92},[],{"trials":1368,"activeCount":92},[],{"trials":1370,"activeCount":92},[1371],{"nctId":441,"briefTitle":442,"status":102,"phases":1372,"primaryCompletion":444,"completion":445,"start":410,"enrollment":321,"conditions":1373,"interventions":1374},[83],[447],[449,450,451,452,390],{"trials":1376,"activeCount":92},[],{"intervention":1378,"totalTrials":123,"cells":1379},"Prilocaine",{"EARLY_PHASE1":1380,"PHASE1":1382,"PHASE2":1384,"PHASE3":1386,"PHASE4":1388,"NA":1398},{"trials":1381,"activeCount":92},[],{"trials":1383,"activeCount":92},[],{"trials":1385,"activeCount":92},[],{"trials":1387,"activeCount":92},[],{"trials":1389,"activeCount":92},[1390],{"nctId":1391,"briefTitle":1392,"status":406,"phases":1393,"primaryCompletion":1394,"completion":1209,"start":1210,"enrollment":611,"conditions":1395,"interventions":1397},"NCT05610007","Comparison of Hyperbaric Prilocaine 2% 50 Mg and Hyperbaric Bupivacaine 0.5% 12.5 Mg Against Spinal Anesthesia Recovery Time in Cystoscopy Procedure",[83],"2022-08-01",[30,1396],"Anesthesia; Reaction",[1378],{"trials":1399,"activeCount":92},[],{"intervention":1401,"totalTrials":123,"cells":1402},"Rabeprazole Sodium 20mg",{"EARLY_PHASE1":1403,"PHASE1":1405,"PHASE2":1407,"PHASE3":1409,"PHASE4":1411,"NA":1426},{"trials":1404,"activeCount":92},[],{"trials":1406,"activeCount":92},[],{"trials":1408,"activeCount":92},[],{"trials":1410,"activeCount":92},[],{"trials":1412,"activeCount":92},[1413],{"nctId":1414,"briefTitle":1415,"status":406,"phases":1416,"primaryCompletion":1417,"completion":1418,"start":1419,"enrollment":1420,"conditions":1421,"interventions":1423},"NCT03134378","10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication",[83],"2017-05-05","2017-05-12","2016-10-03",73,[1422],"Helicobacter Pylori Infection",[1401,1424,1425],"Clarithromycin 500mg","Amoxicillin 500 Mg",{"trials":1427,"activeCount":92},[],{"intervention":1424,"totalTrials":123,"cells":1429},{"EARLY_PHASE1":1430,"PHASE1":1432,"PHASE2":1434,"PHASE3":1436,"PHASE4":1438,"NA":1444},{"trials":1431,"activeCount":92},[],{"trials":1433,"activeCount":92},[],{"trials":1435,"activeCount":92},[],{"trials":1437,"activeCount":92},[],{"trials":1439,"activeCount":92},[1440],{"nctId":1414,"briefTitle":1415,"status":406,"phases":1441,"primaryCompletion":1417,"completion":1418,"start":1419,"enrollment":1420,"conditions":1442,"interventions":1443},[83],[1422],[1401,1424,1425],{"trials":1445,"activeCount":92},[],{"intervention":1425,"totalTrials":123,"cells":1447},{"EARLY_PHASE1":1448,"PHASE1":1450,"PHASE2":1452,"PHASE3":1454,"PHASE4":1456,"NA":1462},{"trials":1449,"activeCount":92},[],{"trials":1451,"activeCount":92},[],{"trials":1453,"activeCount":92},[],{"trials":1455,"activeCount":92},[],{"trials":1457,"activeCount":92},[1458],{"nctId":1414,"briefTitle":1415,"status":406,"phases":1459,"primaryCompletion":1417,"completion":1418,"start":1419,"enrollment":1420,"conditions":1460,"interventions":1461},[83],[1422],[1401,1424,1425],{"trials":1463,"activeCount":92},[],{"intervention":1465,"totalTrials":123,"cells":1466},"n-acetylcysteine",{"EARLY_PHASE1":1467,"PHASE1":1469,"PHASE2":1471,"PHASE3":1473,"PHASE4":1475,"NA":1488},{"trials":1468,"activeCount":92},[],{"trials":1470,"activeCount":92},[],{"trials":1472,"activeCount":92},[],{"trials":1474,"activeCount":92},[],{"trials":1476,"activeCount":92},[1477],{"nctId":1478,"briefTitle":1479,"status":102,"phases":1480,"primaryCompletion":717,"completion":1481,"start":1482,"enrollment":1483,"conditions":1484,"interventions":1487},"NCT05903014","Effectiveness of N-Acetylcysteine (NAC) in Motivational Enhancement Therapy for Nicotine Addiction",[83],"2023-12-30","2023-01-01",90,[1485,1486],"Nicotine Dependence","Nicotine Addiction",[1465],{"trials":1489,"activeCount":92},[],{"intervention":1491,"totalTrials":123,"cells":1492},"shampoo with different composition",{"EARLY_PHASE1":1493,"PHASE1":1495,"PHASE2":1497,"PHASE3":1499,"PHASE4":1501,"NA":1513},{"trials":1494,"activeCount":92},[],{"trials":1496,"activeCount":92},[],{"trials":1498,"activeCount":92},[],{"trials":1500,"activeCount":92},[],{"trials":1502,"activeCount":92},[1503],{"nctId":1504,"briefTitle":1505,"status":102,"phases":1506,"primaryCompletion":1507,"completion":1507,"start":1508,"enrollment":1509,"conditions":1510,"interventions":1512},"NCT04007237","The Comparative Assessment of Mycological Efficacy, Safety, Recurrence, and Cost-effectiveness of Selenium Sulfide 1.8% Shampoo Versus Ketoconazole 2% Shampoo in Pityriasis Versicolor: a Double-blind Randomized Controlled Trial",[83],"2018-12-30","2018-09-01",100,[1511],"Pityriasis Versicolor",[1491],{"trials":1514,"activeCount":92},[],{"intervention":615,"totalTrials":123,"cells":1516},{"EARLY_PHASE1":1517,"PHASE1":1519,"PHASE2":1521,"PHASE3":1523,"PHASE4":1525,"NA":1531},{"trials":1518,"activeCount":92},[],{"trials":1520,"activeCount":92},[],{"trials":1522,"activeCount":92},[],{"trials":1524,"activeCount":92},[],{"trials":1526,"activeCount":92},[1527],{"nctId":606,"briefTitle":607,"status":102,"phases":1528,"primaryCompletion":609,"completion":609,"start":610,"enrollment":611,"conditions":1529,"interventions":1530},[83],[613],[579,615],{"trials":1532,"activeCount":92},[],{"intervention":504,"totalTrials":123,"cells":1534},{"EARLY_PHASE1":1535,"PHASE1":1537,"PHASE2":1539,"PHASE3":1541,"PHASE4":1543,"NA":1549},{"trials":1536,"activeCount":92},[],{"trials":1538,"activeCount":92},[],{"trials":1540,"activeCount":92},[],{"trials":1542,"activeCount":92},[],{"trials":1544,"activeCount":92},[1545],{"nctId":495,"briefTitle":496,"status":102,"phases":1546,"primaryCompletion":498,"completion":499,"start":500,"enrollment":143,"conditions":1547,"interventions":1548},[83],[502],[504,456],{"trials":1550,"activeCount":92},[],{"intervention":479,"totalTrials":88,"cells":1552},{"EARLY_PHASE1":1553,"PHASE1":1555,"PHASE2":1557,"PHASE3":1559,"PHASE4":1569,"NA":1571},{"trials":1554,"activeCount":92},[],{"trials":1556,"activeCount":92},[],{"trials":1558,"activeCount":92},[],{"trials":1560,"activeCount":92},[1561,1565],{"nctId":468,"briefTitle":469,"status":102,"phases":1562,"primaryCompletion":471,"completion":472,"start":473,"enrollment":474,"conditions":1563,"interventions":1564},[81,82],[476,477],[456,479],{"nctId":481,"briefTitle":482,"status":406,"phases":1566,"primaryCompletion":484,"completion":485,"start":486,"enrollment":487,"conditions":1567,"interventions":1568},[81,82],[489,490],[456,479],{"trials":1570,"activeCount":92},[],{"trials":1572,"activeCount":92},[],{"intervention":1574,"totalTrials":88,"cells":1575},"Cholecalciferol",{"EARLY_PHASE1":1576,"PHASE1":1578,"PHASE2":1580,"PHASE3":1582,"PHASE4":1603,"NA":1605},{"trials":1577,"activeCount":92},[],{"trials":1579,"activeCount":92},[],{"trials":1581,"activeCount":92},[],{"trials":1583,"activeCount":92},[1584,1594],{"nctId":1585,"briefTitle":1586,"status":406,"phases":1587,"primaryCompletion":1588,"completion":1588,"start":1589,"enrollment":1590,"conditions":1591,"interventions":1593},"NCT06054919","The Effect of Vitamin D3 Therapy on Vitamin D Status in Pregnant Women With Vitamin D Deficient and Insufficient",[81,82],"2023-11-30","2021-04-01",52,[1592],"Vitamin D Deficiency",[1574],{"nctId":1595,"briefTitle":1596,"status":102,"phases":1597,"primaryCompletion":1598,"completion":1598,"start":1599,"enrollment":342,"conditions":1600,"interventions":1602},"NCT04847947","The Effect of Cholecalciferol in Pre-frail Elderly",[82],"2021-12-31","2021-04-19",[1601],"Pre-frail Elderly",[1574],{"trials":1604,"activeCount":92},[],{"trials":1606,"activeCount":92},[],{"intervention":111,"totalTrials":123,"cells":1608},{"EARLY_PHASE1":1609,"PHASE1":1611,"PHASE2":1613,"PHASE3":1615,"PHASE4":1621,"NA":1623},{"trials":1610,"activeCount":92},[],{"trials":1612,"activeCount":92},[],{"trials":1614,"activeCount":92},[],{"trials":1616,"activeCount":92},[1617],{"nctId":100,"briefTitle":101,"status":102,"phases":1618,"primaryCompletion":104,"completion":105,"start":106,"enrollment":107,"conditions":1619,"interventions":1620},[82],[109],[111,87],{"trials":1622,"activeCount":92},[],{"trials":1624,"activeCount":92},[],{"intervention":1626,"totalTrials":123,"cells":1627},"3 % Topical Tranexamic Acid",{"EARLY_PHASE1":1628,"PHASE1":1630,"PHASE2":1632,"PHASE3":1634,"PHASE4":1644,"NA":1646},{"trials":1629,"activeCount":92},[],{"trials":1631,"activeCount":92},[],{"trials":1633,"activeCount":92},[],{"trials":1635,"activeCount":92},[1636],{"nctId":1637,"briefTitle":1638,"status":406,"phases":1639,"primaryCompletion":716,"completion":717,"start":718,"enrollment":1640,"conditions":1641,"interventions":1642},"NCT06010810","The Effectiveness of 3% Topical Tranexamic Acid Compared to 4% Topical Hydroquinone as Therapy of Melasma",[82],20,[283],[1626,1643],"4% Topical Hidroquinone",{"trials":1645,"activeCount":92},[],{"trials":1647,"activeCount":92},[],{"intervention":1643,"totalTrials":123,"cells":1649},{"EARLY_PHASE1":1650,"PHASE1":1652,"PHASE2":1654,"PHASE3":1656,"PHASE4":1662,"NA":1664},{"trials":1651,"activeCount":92},[],{"trials":1653,"activeCount":92},[],{"trials":1655,"activeCount":92},[],{"trials":1657,"activeCount":92},[1658],{"nctId":1637,"briefTitle":1638,"status":406,"phases":1659,"primaryCompletion":716,"completion":717,"start":718,"enrollment":1640,"conditions":1660,"interventions":1661},[82],[283],[1626,1643],{"trials":1663,"activeCount":92},[],{"trials":1665,"activeCount":92},[],{"intervention":1667,"totalTrials":123,"cells":1668},"Single dose of celecoxib 400 mg and pregabalin 150 mg",{"EARLY_PHASE1":1669,"PHASE1":1671,"PHASE2":1673,"PHASE3":1675,"PHASE4":1691,"NA":1693},{"trials":1670,"activeCount":92},[],{"trials":1672,"activeCount":92},[],{"trials":1674,"activeCount":92},[],{"trials":1676,"activeCount":92},[1677],{"nctId":1678,"briefTitle":1679,"status":406,"phases":1680,"primaryCompletion":1681,"completion":1682,"start":568,"enrollment":1683,"conditions":1684,"interventions":1689},"NCT05509946","Preemptive Analgesia Combination of Celecoxib and Pregabalin in THA",[81,82],"2023-04-01","2023-04-30",30,[1685,1686,1687,1688],"Arthroplasty Complications","Analgetic","Celecoxib","Pregabalin",[1667,1690],"Repeated dose of celecoxib 200 mg and pregabalin 75 mg",{"trials":1692,"activeCount":92},[],{"trials":1694,"activeCount":92},[],{"intervention":1690,"totalTrials":123,"cells":1696},{"EARLY_PHASE1":1697,"PHASE1":1699,"PHASE2":1701,"PHASE3":1703,"PHASE4":1709,"NA":1711},{"trials":1698,"activeCount":92},[],{"trials":1700,"activeCount":92},[],{"trials":1702,"activeCount":92},[],{"trials":1704,"activeCount":92},[1705],{"nctId":1678,"briefTitle":1679,"status":406,"phases":1706,"primaryCompletion":1681,"completion":1682,"start":568,"enrollment":1683,"conditions":1707,"interventions":1708},[81,82],[1685,1686,1687,1688],[1667,1690],{"trials":1710,"activeCount":92},[],{"trials":1712,"activeCount":92},[],{"intervention":1714,"totalTrials":123,"cells":1715},"Propylthiouracil",{"EARLY_PHASE1":1716,"PHASE1":1718,"PHASE2":1720,"PHASE3":1722,"PHASE4":1738,"NA":1740},{"trials":1717,"activeCount":92},[],{"trials":1719,"activeCount":92},[],{"trials":1721,"activeCount":92},[],{"trials":1723,"activeCount":92},[1724],{"nctId":1725,"briefTitle":1726,"status":102,"phases":1727,"primaryCompletion":1728,"completion":1729,"start":1730,"enrollment":719,"conditions":1731,"interventions":1736},"NCT05118542","Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis",[82],"2020-06-01","2020-08-01","2019-01-01",[1732,1733,1734,1735],"Hyperthyroidism","Graves Disease","Atherosclerosis of Artery","Pathophysiology",[1714,1737],"Methimazole",{"trials":1739,"activeCount":92},[],{"trials":1741,"activeCount":92},[],{"intervention":1737,"totalTrials":123,"cells":1743},{"EARLY_PHASE1":1744,"PHASE1":1746,"PHASE2":1748,"PHASE3":1750,"PHASE4":1756,"NA":1758},{"trials":1745,"activeCount":92},[],{"trials":1747,"activeCount":92},[],{"trials":1749,"activeCount":92},[],{"trials":1751,"activeCount":92},[1752],{"nctId":1725,"briefTitle":1726,"status":102,"phases":1753,"primaryCompletion":1728,"completion":1729,"start":1730,"enrollment":719,"conditions":1754,"interventions":1755},[82],[1732,1733,1734,1735],[1714,1737],{"trials":1757,"activeCount":92},[],{"trials":1759,"activeCount":92},[],{"intervention":1761,"totalTrials":123,"cells":1762},"Metformin",{"EARLY_PHASE1":1763,"PHASE1":1765,"PHASE2":1767,"PHASE3":1769,"PHASE4":1781,"NA":1783},{"trials":1764,"activeCount":92},[],{"trials":1766,"activeCount":92},[],{"trials":1768,"activeCount":92},[],{"trials":1770,"activeCount":92},[1771],{"nctId":1772,"briefTitle":1773,"status":406,"phases":1774,"primaryCompletion":1775,"completion":1776,"start":1777,"enrollment":1778,"conditions":1779,"interventions":1780},"NCT02325245","Effects of Metformin in Pre-frail Elderly",[82],"2016-12","2017-03","2015-03",150,[1601],[1761],{"trials":1782,"activeCount":92},[],{"trials":1784,"activeCount":92},[],{"intervention":602,"totalTrials":123,"cells":1786},{"EARLY_PHASE1":1787,"PHASE1":1789,"PHASE2":1791,"PHASE3":1793,"PHASE4":1799,"NA":1801},{"trials":1788,"activeCount":92},[],{"trials":1790,"activeCount":92},[],{"trials":1792,"activeCount":92},[],{"trials":1794,"activeCount":92},[1795],{"nctId":590,"briefTitle":591,"status":102,"phases":1796,"primaryCompletion":593,"completion":594,"start":595,"enrollment":596,"conditions":1797,"interventions":1798},[82],[598,599,600],[579,602],{"trials":1800,"activeCount":92},[],{"trials":1802,"activeCount":92},[],{"intervention":1804,"totalTrials":123,"cells":1805},"Umbilical Cord Mesenchymal Stem Cell transplantation",{"EARLY_PHASE1":1806,"PHASE1":1808,"PHASE2":1810,"PHASE3":1812,"PHASE4":1823,"NA":1825},{"trials":1807,"activeCount":92},[],{"trials":1809,"activeCount":92},[],{"trials":1811,"activeCount":92},[],{"trials":1813,"activeCount":92},[1814],{"nctId":1815,"briefTitle":1816,"status":406,"phases":1817,"primaryCompletion":1818,"completion":1818,"start":1819,"enrollment":182,"conditions":1820,"interventions":1822},"NCT05935423","Umbilical Cord Mesenchymal Stem Cell Improve Cardiac Function on ST-elevation Myocardial Infarction (STEMI) Patients",[82],"2024-07","2023-07",[1821],"ST Elevation Myocardial Infarction",[1804],{"trials":1824,"activeCount":92},[],{"trials":1826,"activeCount":92},[],{"intervention":1828,"totalTrials":123,"cells":1829},"Norepinephrine",{"EARLY_PHASE1":1830,"PHASE1":1832,"PHASE2":1834,"PHASE3":1836,"PHASE4":1849,"NA":1851},{"trials":1831,"activeCount":92},[],{"trials":1833,"activeCount":92},[],{"trials":1835,"activeCount":92},[],{"trials":1837,"activeCount":92},[1838],{"nctId":1839,"briefTitle":1840,"status":102,"phases":1841,"primaryCompletion":1842,"completion":1842,"start":1843,"enrollment":1844,"conditions":1845,"interventions":1847},"NCT06461390","The Effect of Early Norepinephrine on Stroke Volume Index, Cardiac Index, Lactate, and Arterial Elastance in Pediatric Septic Shock",[81,82],"2024-05-31","2024-03-25",42,[1846,18],"Septic Shock",[1828,1848],"Ringer's Lactate",{"trials":1850,"activeCount":92},[],{"trials":1852,"activeCount":92},[],{"intervention":1848,"totalTrials":123,"cells":1854},{"EARLY_PHASE1":1855,"PHASE1":1857,"PHASE2":1859,"PHASE3":1861,"PHASE4":1867,"NA":1869},{"trials":1856,"activeCount":92},[],{"trials":1858,"activeCount":92},[],{"trials":1860,"activeCount":92},[],{"trials":1862,"activeCount":92},[1863],{"nctId":1839,"briefTitle":1840,"status":102,"phases":1864,"primaryCompletion":1842,"completion":1842,"start":1843,"enrollment":1844,"conditions":1865,"interventions":1866},[81,82],[1846,18],[1828,1848],{"trials":1868,"activeCount":92},[],{"trials":1870,"activeCount":92},[],{"intervention":1872,"totalTrials":123,"cells":1873},"Simvastatin",{"EARLY_PHASE1":1874,"PHASE1":1876,"PHASE2":1878,"PHASE3":1880,"PHASE4":1893,"NA":1895},{"trials":1875,"activeCount":92},[],{"trials":1877,"activeCount":92},[],{"trials":1879,"activeCount":92},[],{"trials":1881,"activeCount":92},[1882],{"nctId":1883,"briefTitle":1884,"status":406,"phases":1885,"primaryCompletion":1886,"completion":1887,"start":1888,"enrollment":1889,"conditions":1890,"interventions":1892},"NCT01651728","Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients",[82],"2013-08","2013-09","2012-07",200,[1891],"Community-Acquired Pneumonia",[1872],{"trials":1894,"activeCount":92},[],{"trials":1896,"activeCount":92},[],{"intervention":1898,"totalTrials":123,"cells":1899},"Colchicine",{"EARLY_PHASE1":1900,"PHASE1":1902,"PHASE2":1904,"PHASE3":1906,"PHASE4":1917,"NA":1919},{"trials":1901,"activeCount":92},[],{"trials":1903,"activeCount":92},[],{"trials":1905,"activeCount":92},[],{"trials":1907,"activeCount":92},[1908],{"nctId":1909,"briefTitle":1910,"status":406,"phases":1911,"primaryCompletion":1912,"completion":1912,"start":1913,"enrollment":434,"conditions":1914,"interventions":1916},"NCT05734612","The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury",[82],"2023-03-31","2022-12-04",[1915],"Reperfusion Injury, Myocardial",[1898],{"trials":1918,"activeCount":92},[],{"trials":1920,"activeCount":92},[],{"intervention":1922,"totalTrials":123,"cells":1923},"Convalescent plasma",{"EARLY_PHASE1":1924,"PHASE1":1926,"PHASE2":1928,"PHASE3":1930,"PHASE4":1943,"NA":1945},{"trials":1925,"activeCount":92},[],{"trials":1927,"activeCount":92},[],{"trials":1929,"activeCount":92},[],{"trials":1931,"activeCount":92},[1932],{"nctId":1933,"briefTitle":1934,"status":406,"phases":1935,"primaryCompletion":1936,"completion":1936,"start":1937,"enrollment":182,"conditions":1938,"interventions":1941},"NCT04380935","Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome",[81,82],"2020-10-31","2020-05-18",[1939,1940],"COVID","Acute Respiratory Distress Syndrome",[1922,1942],"Standard of care",{"trials":1944,"activeCount":92},[],{"trials":1946,"activeCount":92},[],{"intervention":1942,"totalTrials":123,"cells":1948},{"EARLY_PHASE1":1949,"PHASE1":1951,"PHASE2":1953,"PHASE3":1955,"PHASE4":1961,"NA":1963},{"trials":1950,"activeCount":92},[],{"trials":1952,"activeCount":92},[],{"trials":1954,"activeCount":92},[],{"trials":1956,"activeCount":92},[1957],{"nctId":1933,"briefTitle":1934,"status":406,"phases":1958,"primaryCompletion":1936,"completion":1936,"start":1937,"enrollment":182,"conditions":1959,"interventions":1960},[81,82],[1939,1940],[1922,1942],{"trials":1962,"activeCount":92},[],{"trials":1964,"activeCount":92},[],{"intervention":1966,"totalTrials":123,"cells":1967},"Albumins",{"EARLY_PHASE1":1968,"PHASE1":1970,"PHASE2":1972,"PHASE3":1974,"PHASE4":1987,"NA":1989},{"trials":1969,"activeCount":92},[],{"trials":1971,"activeCount":92},[],{"trials":1973,"activeCount":92},[],{"trials":1975,"activeCount":92},[1976],{"nctId":1977,"briefTitle":1978,"status":406,"phases":1979,"primaryCompletion":1980,"completion":1980,"start":1981,"enrollment":1982,"conditions":1983,"interventions":1985},"NCT04076254","Resuscitation With Albumin 5% in Dengue Haemorrhagic Fever",[82],"2019-09","2016-10",84,[1984],"Dengue Hemorrhagic",[1966,1986],"Fluid",{"trials":1988,"activeCount":92},[],{"trials":1990,"activeCount":92},[],{"intervention":1986,"totalTrials":123,"cells":1992},{"EARLY_PHASE1":1993,"PHASE1":1995,"PHASE2":1997,"PHASE3":1999,"PHASE4":2005,"NA":2007},{"trials":1994,"activeCount":92},[],{"trials":1996,"activeCount":92},[],{"trials":1998,"activeCount":92},[],{"trials":2000,"activeCount":92},[2001],{"nctId":1977,"briefTitle":1978,"status":406,"phases":2002,"primaryCompletion":1980,"completion":1980,"start":1981,"enrollment":1982,"conditions":2003,"interventions":2004},[82],[1984],[1966,1986],{"trials":2006,"activeCount":92},[],{"trials":2008,"activeCount":92},[],{"intervention":2010,"totalTrials":123,"cells":2011},"Trimetazidine",{"EARLY_PHASE1":2012,"PHASE1":2014,"PHASE2":2016,"PHASE3":2018,"PHASE4":2030,"NA":2032},{"trials":2013,"activeCount":92},[],{"trials":2015,"activeCount":92},[],{"trials":2017,"activeCount":92},[],{"trials":2019,"activeCount":92},[2020],{"nctId":2021,"briefTitle":2022,"status":102,"phases":2023,"primaryCompletion":2024,"completion":2025,"start":2026,"enrollment":191,"conditions":2027,"interventions":2029},"NCT03273387","The Role of Trimetazidine on Right Ventricle Function in Pulmonary Arterial Hypertension",[81,82],"2018-11-01","2018-12-14","2017-09-10",[2028],"Precapillary Pulmonary Hypertension",[2010],{"trials":2031,"activeCount":92},[],{"trials":2033,"activeCount":92},[],{"intervention":2035,"totalTrials":123,"cells":2036},"Nigella sativa",{"EARLY_PHASE1":2037,"PHASE1":2039,"PHASE2":2041,"PHASE3":2043,"PHASE4":2055,"NA":2057},{"trials":2038,"activeCount":92},[],{"trials":2040,"activeCount":92},[],{"trials":2042,"activeCount":92},[],{"trials":2044,"activeCount":92},[2045],{"nctId":2046,"briefTitle":2047,"status":406,"phases":2048,"primaryCompletion":2049,"completion":1280,"start":2050,"enrollment":2051,"conditions":2052,"interventions":2054},"NCT01393054","Effect of Nigella Sativa Seed Extract on the Blood Pressure of Elderly With Hypertension",[82],"2011-10","2011-07",76,[2053],"Hypertension",[2035],{"trials":2056,"activeCount":92},[],{"trials":2058,"activeCount":92},[],{"intervention":2060,"totalTrials":123,"cells":2061},"Melatonin 20 MG Oral",{"EARLY_PHASE1":2062,"PHASE1":2064,"PHASE2":2066,"PHASE3":2068,"PHASE4":2080,"NA":2082},{"trials":2063,"activeCount":92},[],{"trials":2065,"activeCount":92},[],{"trials":2067,"activeCount":92},[],{"trials":2069,"activeCount":92},[2070],{"nctId":2071,"briefTitle":2072,"status":102,"phases":2073,"primaryCompletion":1101,"completion":2074,"start":2075,"enrollment":214,"conditions":2076,"interventions":2079},"NCT04137627","Melatonin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response in Locally Advanced Oral Squamous Cell Carcinoma",[82],"2018-12-18","2017-07-04",[2077,2078],"Oral Squamous Cell Carcinoma","Neoadjuvant Chemotherapy",[2060],{"trials":2081,"activeCount":92},[],{"trials":2083,"activeCount":92},[],{"intervention":2085,"totalTrials":123,"cells":2086},"Curcumin Oral",{"EARLY_PHASE1":2087,"PHASE1":2089,"PHASE2":2091,"PHASE3":2093,"PHASE4":2106,"NA":2108},{"trials":2088,"activeCount":92},[],{"trials":2090,"activeCount":92},[],{"trials":2092,"activeCount":92},[],{"trials":2094,"activeCount":92},[2095],{"nctId":2096,"briefTitle":2097,"status":102,"phases":2098,"primaryCompletion":2099,"completion":2099,"start":2100,"enrollment":2101,"conditions":2102,"interventions":2104},"NCT06281353","The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue",[81,82],"2023-09-06","2022-08-16",78,[2103],"Anogenital Wart",[2085,2105],"Trichloroacetic acid",{"trials":2107,"activeCount":92},[],{"trials":2109,"activeCount":92},[],{"intervention":2105,"totalTrials":123,"cells":2111},{"EARLY_PHASE1":2112,"PHASE1":2114,"PHASE2":2116,"PHASE3":2118,"PHASE4":2124,"NA":2126},{"trials":2113,"activeCount":92},[],{"trials":2115,"activeCount":92},[],{"trials":2117,"activeCount":92},[],{"trials":2119,"activeCount":92},[2120],{"nctId":2096,"briefTitle":2097,"status":102,"phases":2121,"primaryCompletion":2099,"completion":2099,"start":2100,"enrollment":2101,"conditions":2122,"interventions":2123},[81,82],[2103],[2085,2105],{"trials":2125,"activeCount":92},[],{"trials":2127,"activeCount":92},[],{"intervention":2129,"totalTrials":123,"cells":2130},"Unfractionated heparin",{"EARLY_PHASE1":2131,"PHASE1":2133,"PHASE2":2135,"PHASE3":2137,"PHASE4":2150,"NA":2152},{"trials":2132,"activeCount":92},[],{"trials":2134,"activeCount":92},[],{"trials":2136,"activeCount":92},[],{"trials":2138,"activeCount":92},[2139],{"nctId":2140,"briefTitle":2141,"status":102,"phases":2142,"primaryCompletion":2143,"completion":2143,"start":2144,"enrollment":2145,"conditions":2146,"interventions":2149},"NCT02135770","Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis",[82],"2014-06","2013-01",115,[2147,2148],"Severe Sepsis With Septic Shock","Severe Sepsis Without Septic Shock",[2129],{"trials":2151,"activeCount":92},[],{"trials":2153,"activeCount":92},[],{"intervention":2155,"totalTrials":123,"cells":2156},"Finasteride",{"EARLY_PHASE1":2157,"PHASE1":2159,"PHASE2":2161,"PHASE3":2163,"PHASE4":2173,"NA":2175},{"trials":2158,"activeCount":92},[],{"trials":2160,"activeCount":92},[],{"trials":2162,"activeCount":92},[],{"trials":2164,"activeCount":92},[2165],{"nctId":2166,"briefTitle":2167,"status":406,"phases":2168,"primaryCompletion":2169,"completion":1481,"start":814,"enrollment":596,"conditions":2170,"interventions":2171},"NCT05990400","Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia",[81,82],"2023-10-30",[721],[2155,2172],"Minoxidil",{"trials":2174,"activeCount":92},[],{"trials":2176,"activeCount":92},[],{"intervention":2172,"totalTrials":123,"cells":2178},{"EARLY_PHASE1":2179,"PHASE1":2181,"PHASE2":2183,"PHASE3":2185,"PHASE4":2191,"NA":2193},{"trials":2180,"activeCount":92},[],{"trials":2182,"activeCount":92},[],{"trials":2184,"activeCount":92},[],{"trials":2186,"activeCount":92},[2187],{"nctId":2166,"briefTitle":2167,"status":406,"phases":2188,"primaryCompletion":2169,"completion":1481,"start":814,"enrollment":596,"conditions":2189,"interventions":2190},[81,82],[721],[2155,2172],{"trials":2192,"activeCount":92},[],{"trials":2194,"activeCount":92},[],{"intervention":2196,"totalTrials":123,"cells":2197},"Ammonium Lactate",{"EARLY_PHASE1":2198,"PHASE1":2200,"PHASE2":2202,"PHASE3":2204,"PHASE4":2215,"NA":2217},{"trials":2199,"activeCount":92},[],{"trials":2201,"activeCount":92},[],{"trials":2203,"activeCount":92},[],{"trials":2205,"activeCount":92},[2206],{"nctId":2207,"briefTitle":2208,"status":102,"phases":2209,"primaryCompletion":2210,"completion":2210,"start":2211,"enrollment":596,"conditions":2212,"interventions":2213},"NCT04127513","Comparison of 12% Ammonium Lactate and 10% Urea Cream in Geriatric With Xerosis Cutis",[82],"2017-05-31","2017-04-01",[1104],[2196,2214],"Urea",{"trials":2216,"activeCount":92},[],{"trials":2218,"activeCount":92},[],{"intervention":2214,"totalTrials":123,"cells":2220},{"EARLY_PHASE1":2221,"PHASE1":2223,"PHASE2":2225,"PHASE3":2227,"PHASE4":2233,"NA":2235},{"trials":2222,"activeCount":92},[],{"trials":2224,"activeCount":92},[],{"trials":2226,"activeCount":92},[],{"trials":2228,"activeCount":92},[2229],{"nctId":2207,"briefTitle":2208,"status":102,"phases":2230,"primaryCompletion":2210,"completion":2210,"start":2211,"enrollment":596,"conditions":2231,"interventions":2232},[82],[1104],[2196,2214],{"trials":2234,"activeCount":92},[],{"trials":2236,"activeCount":92},[],{"intervention":2238,"totalTrials":123,"cells":2239},"Low molecular weight hyaluronic acid",{"EARLY_PHASE1":2240,"PHASE1":2242,"PHASE2":2244,"PHASE3":2246,"PHASE4":2257,"NA":2259},{"trials":2241,"activeCount":92},[],{"trials":2243,"activeCount":92},[],{"trials":2245,"activeCount":92},[],{"trials":2247,"activeCount":92},[2248],{"nctId":2249,"briefTitle":2250,"status":102,"phases":2251,"primaryCompletion":717,"completion":717,"start":2252,"enrollment":719,"conditions":2253,"interventions":2254},"NCT06178367","Effectiveness and Safety of Topical Hyaluronic Acid of Different Molecular Weights in Xerotic Skin Treatment",[82],"2023-08-26",[1104],[2238,2255,2256],"High molecular weight hyaluronic acid","Vehicle",{"trials":2258,"activeCount":92},[],{"trials":2260,"activeCount":92},[],{"intervention":2255,"totalTrials":123,"cells":2262},{"EARLY_PHASE1":2263,"PHASE1":2265,"PHASE2":2267,"PHASE3":2269,"PHASE4":2275,"NA":2277},{"trials":2264,"activeCount":92},[],{"trials":2266,"activeCount":92},[],{"trials":2268,"activeCount":92},[],{"trials":2270,"activeCount":92},[2271],{"nctId":2249,"briefTitle":2250,"status":102,"phases":2272,"primaryCompletion":717,"completion":717,"start":2252,"enrollment":719,"conditions":2273,"interventions":2274},[82],[1104],[2238,2255,2256],{"trials":2276,"activeCount":92},[],{"trials":2278,"activeCount":92},[],{"intervention":2256,"totalTrials":123,"cells":2280},{"EARLY_PHASE1":2281,"PHASE1":2283,"PHASE2":2285,"PHASE3":2287,"PHASE4":2293,"NA":2295},{"trials":2282,"activeCount":92},[],{"trials":2284,"activeCount":92},[],{"trials":2286,"activeCount":92},[],{"trials":2288,"activeCount":92},[2289],{"nctId":2249,"briefTitle":2250,"status":102,"phases":2290,"primaryCompletion":717,"completion":717,"start":2252,"enrollment":719,"conditions":2291,"interventions":2292},[82],[1104],[2238,2255,2256],{"trials":2294,"activeCount":92},[],{"trials":2296,"activeCount":92},[],{"intervention":2298,"totalTrials":123,"cells":2299},"Minoxidil 5% Topical Solution",{"EARLY_PHASE1":2300,"PHASE1":2302,"PHASE2":2304,"PHASE3":2306,"PHASE4":2315,"NA":2317},{"trials":2301,"activeCount":92},[],{"trials":2303,"activeCount":92},[],{"trials":2305,"activeCount":92},[],{"trials":2307,"activeCount":92},[2308],{"nctId":2309,"briefTitle":2310,"status":102,"phases":2311,"primaryCompletion":716,"completion":2312,"start":718,"enrollment":719,"conditions":2313,"interventions":2314},"NCT05989165","Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men",[82],"2023-09-15",[721],[2298],{"trials":2316,"activeCount":92},[],{"trials":2318,"activeCount":92},[],{"intervention":2320,"totalTrials":123,"cells":2321},"Pharmacology treatment",{"EARLY_PHASE1":2322,"PHASE1":2324,"PHASE2":2326,"PHASE3":2328,"PHASE4":2339,"NA":2341},{"trials":2323,"activeCount":92},[],{"trials":2325,"activeCount":92},[],{"trials":2327,"activeCount":92},[],{"trials":2329,"activeCount":92},[2330],{"nctId":2331,"briefTitle":2332,"status":102,"phases":2333,"primaryCompletion":2334,"completion":2334,"start":421,"enrollment":2335,"conditions":2336,"interventions":2338},"NCT05276336","The Effect of Early Radiofrequency Turbinate Reduction on Persistent Allergic Rhinitis",[82],"2020-02-01",32,[2337],"Allergic Rhinitis",[2320],{"trials":2340,"activeCount":92},[],{"trials":2342,"activeCount":92},[],{"intervention":2344,"totalTrials":123,"cells":2345},"Paracetamol injection and Ibuprofen",{"EARLY_PHASE1":2346,"PHASE1":2348,"PHASE2":2350,"PHASE3":2352,"PHASE4":2366,"NA":2368},{"trials":2347,"activeCount":92},[],{"trials":2349,"activeCount":92},[],{"trials":2351,"activeCount":92},[],{"trials":2353,"activeCount":92},[2354],{"nctId":2355,"briefTitle":2356,"status":102,"phases":2357,"primaryCompletion":2358,"completion":2359,"start":2360,"enrollment":719,"conditions":2361,"interventions":2363},"NCT04414995","Effect of Paracetamol and Ibuprofen Reducing Morphine Requirements After Total Knee Arthroplasty",[81,82],"2020-11-30","2020-12-15","2020-06-05",[2362],"Analgesia",[2344,2364,2365],"Paracetamol injection and normal saline","Ibuprofen Injection and normal saline",{"trials":2367,"activeCount":92},[],{"trials":2369,"activeCount":92},[],{"intervention":2364,"totalTrials":123,"cells":2371},{"EARLY_PHASE1":2372,"PHASE1":2374,"PHASE2":2376,"PHASE3":2378,"PHASE4":2384,"NA":2386},{"trials":2373,"activeCount":92},[],{"trials":2375,"activeCount":92},[],{"trials":2377,"activeCount":92},[],{"trials":2379,"activeCount":92},[2380],{"nctId":2355,"briefTitle":2356,"status":102,"phases":2381,"primaryCompletion":2358,"completion":2359,"start":2360,"enrollment":719,"conditions":2382,"interventions":2383},[81,82],[2362],[2344,2364,2365],{"trials":2385,"activeCount":92},[],{"trials":2387,"activeCount":92},[],{"intervention":2365,"totalTrials":123,"cells":2389},{"EARLY_PHASE1":2390,"PHASE1":2392,"PHASE2":2394,"PHASE3":2396,"PHASE4":2402,"NA":2404},{"trials":2391,"activeCount":92},[],{"trials":2393,"activeCount":92},[],{"trials":2395,"activeCount":92},[],{"trials":2397,"activeCount":92},[2398],{"nctId":2355,"briefTitle":2356,"status":102,"phases":2399,"primaryCompletion":2358,"completion":2359,"start":2360,"enrollment":719,"conditions":2400,"interventions":2401},[81,82],[2362],[2344,2364,2365],{"trials":2403,"activeCount":92},[],{"trials":2405,"activeCount":92},[],{"intervention":2407,"totalTrials":123,"cells":2408},"Favipiravir",{"EARLY_PHASE1":2409,"PHASE1":2411,"PHASE2":2413,"PHASE3":2415,"PHASE4":2428,"NA":2430},{"trials":2410,"activeCount":92},[],{"trials":2412,"activeCount":92},[],{"trials":2414,"activeCount":92},[],{"trials":2416,"activeCount":92},[2417],{"nctId":2418,"briefTitle":2419,"status":406,"phases":2420,"primaryCompletion":2421,"completion":2422,"start":2423,"enrollment":1509,"conditions":2424,"interventions":2426},"NCT04558463","The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19",[82],"2020-09-30","2020-10-30","2020-04-16",[2425],"Covid19",[2407,2427],"Oseltamivir 75mg",{"trials":2429,"activeCount":92},[],{"trials":2431,"activeCount":92},[],{"intervention":2427,"totalTrials":123,"cells":2433},{"EARLY_PHASE1":2434,"PHASE1":2436,"PHASE2":2438,"PHASE3":2440,"PHASE4":2446,"NA":2448},{"trials":2435,"activeCount":92},[],{"trials":2437,"activeCount":92},[],{"trials":2439,"activeCount":92},[],{"trials":2441,"activeCount":92},[2442],{"nctId":2418,"briefTitle":2419,"status":406,"phases":2443,"primaryCompletion":2421,"completion":2422,"start":2423,"enrollment":1509,"conditions":2444,"interventions":2445},[82],[2425],[2407,2427],{"trials":2447,"activeCount":92},[],{"trials":2449,"activeCount":92},[],{"intervention":2451,"totalTrials":123,"cells":2452},"Injection of secretome - mesenchymal stem cell",{"EARLY_PHASE1":2453,"PHASE1":2455,"PHASE2":2457,"PHASE3":2459,"PHASE4":2472,"NA":2474},{"trials":2454,"activeCount":92},[],{"trials":2456,"activeCount":92},[],{"trials":2458,"activeCount":92},[],{"trials":2460,"activeCount":92},[2461],{"nctId":2462,"briefTitle":2463,"status":102,"phases":2464,"primaryCompletion":2465,"completion":2466,"start":2467,"enrollment":596,"conditions":2468,"interventions":2470},"NCT05122234","Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19",[82],"2021-07-30","2021-11-14","2020-08-10",[2469],"COVID-19",[2451,2471],"Standard treatment of Covid-19",{"trials":2473,"activeCount":92},[],{"trials":2475,"activeCount":92},[],{"intervention":2471,"totalTrials":123,"cells":2477},{"EARLY_PHASE1":2478,"PHASE1":2480,"PHASE2":2482,"PHASE3":2484,"PHASE4":2490,"NA":2492},{"trials":2479,"activeCount":92},[],{"trials":2481,"activeCount":92},[],{"trials":2483,"activeCount":92},[],{"trials":2485,"activeCount":92},[2486],{"nctId":2462,"briefTitle":2463,"status":102,"phases":2487,"primaryCompletion":2465,"completion":2466,"start":2467,"enrollment":596,"conditions":2488,"interventions":2489},[82],[2469],[2451,2471],{"trials":2491,"activeCount":92},[],{"trials":2493,"activeCount":92},[],{"intervention":2495,"totalTrials":123,"cells":2496},"stem cells",{"EARLY_PHASE1":2497,"PHASE1":2499,"PHASE2":2501,"PHASE3":2503,"PHASE4":2516,"NA":2518},{"trials":2498,"activeCount":92},[],{"trials":2500,"activeCount":92},[],{"trials":2502,"activeCount":92},[],{"trials":2504,"activeCount":92},[2505],{"nctId":2506,"briefTitle":2507,"status":406,"phases":2508,"primaryCompletion":566,"completion":2509,"start":2510,"enrollment":2511,"conditions":2512,"interventions":2515},"NCT04972890","The Outcomes of Intracavernosal Umbilical Cord Mesenchymal Stem Cells Implantation in Patients With Diabetic Erectile Dysfunction",[81,82],"2023-01-31","2020-10-27",12,[2513,2514],"Urologic Diseases","Erectile Dysfunction With Diabetes Mellitus",[2495],{"trials":2517,"activeCount":92},[],{"trials":2519,"activeCount":92},[],{"intervention":2521,"totalTrials":123,"cells":2522},"probiotics",{"EARLY_PHASE1":2523,"PHASE1":2525,"PHASE2":2527,"PHASE3":2529,"PHASE4":2540,"NA":2542},{"trials":2524,"activeCount":92},[],{"trials":2526,"activeCount":92},[],{"trials":2528,"activeCount":92},[],{"trials":2530,"activeCount":92},[2531],{"nctId":2532,"briefTitle":2533,"status":406,"phases":2534,"primaryCompletion":2535,"completion":2535,"start":2536,"enrollment":182,"conditions":2537,"interventions":2539},"NCT04787419","Probiotics in Pediatric Chronic Cholestasis",[81,82],"2023-12-01","2020-09-01",[2538],"Cholestatic Liver Disease",[2521],{"trials":2541,"activeCount":92},[],{"trials":2543,"activeCount":92},[],{"intervention":2545,"totalTrials":123,"cells":2546},"Placebos",{"EARLY_PHASE1":2547,"PHASE1":2549,"PHASE2":2551,"PHASE3":2553,"PHASE4":2569,"NA":2571},{"trials":2548,"activeCount":92},[],{"trials":2550,"activeCount":92},[],{"trials":2552,"activeCount":92},[],{"trials":2554,"activeCount":92},[2555],{"nctId":2556,"briefTitle":2557,"status":406,"phases":2558,"primaryCompletion":2559,"completion":2559,"start":2560,"enrollment":611,"conditions":2561,"interventions":2567},"NCT03991910","The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients",[82],"2024-08-08","2019-06-27",[2562,2563,2564,2565,2566],"Rheumatic Heart Disease","Mitral Stenosis","Rheumatic Mitral Stenosis","Fibrosis; Heart","ACE Inhibitor",[2545,2568],"Ramipril 5Mg Oral",{"trials":2570,"activeCount":92},[],{"trials":2572,"activeCount":92},[],{"intervention":2568,"totalTrials":123,"cells":2574},{"EARLY_PHASE1":2575,"PHASE1":2577,"PHASE2":2579,"PHASE3":2581,"PHASE4":2587,"NA":2589},{"trials":2576,"activeCount":92},[],{"trials":2578,"activeCount":92},[],{"trials":2580,"activeCount":92},[],{"trials":2582,"activeCount":92},[2583],{"nctId":2556,"briefTitle":2557,"status":406,"phases":2584,"primaryCompletion":2559,"completion":2559,"start":2560,"enrollment":611,"conditions":2585,"interventions":2586},[82],[2562,2563,2564,2565,2566],[2545,2568],{"trials":2588,"activeCount":92},[],{"trials":2590,"activeCount":92},[],{"intervention":2592,"totalTrials":123,"cells":2593},"Standard General Anesthesia Induction Using Propofol, Fentanyl and Midazolam",{"EARLY_PHASE1":2594,"PHASE1":2596,"PHASE2":2598,"PHASE3":2600,"PHASE4":2616,"NA":2618},{"trials":2595,"activeCount":92},[],{"trials":2597,"activeCount":92},[],{"trials":2599,"activeCount":92},[],{"trials":2601,"activeCount":92},[2602],{"nctId":2603,"briefTitle":2604,"status":102,"phases":2605,"primaryCompletion":2606,"completion":2606,"start":2607,"enrollment":2608,"conditions":2609,"interventions":2615},"NCT07019805","What Causes Low Blood Pressure After Anesthesia in Older Adults Having Non-Heart Surgery ?",[82],"2025-03-15","2024-09-01",220,[2610,2611,2612,2613,2614],"Geriatric","General Anesthesia Induced Hypotension","Elective Surgery","Hypotension","Risk Factor",[2592],{"trials":2617,"activeCount":92},[],{"trials":2619,"activeCount":92},[],{"intervention":2621,"totalTrials":88,"cells":2622},"DLBS1033",{"EARLY_PHASE1":2623,"PHASE1":2625,"PHASE2":2627,"PHASE3":2647,"PHASE4":2649,"NA":2651},{"trials":2624,"activeCount":92},[],{"trials":2626,"activeCount":92},[],{"trials":2628,"activeCount":92},[2629,2638],{"nctId":2630,"briefTitle":2631,"status":102,"phases":2632,"primaryCompletion":2633,"completion":523,"start":1888,"enrollment":2634,"conditions":2635,"interventions":2637},"NCT01694537","The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers",[81],"2012-10",21,[2636],"Healthy",[2621],{"nctId":2639,"briefTitle":2640,"status":102,"phases":2641,"primaryCompletion":1887,"completion":2642,"start":648,"enrollment":2643,"conditions":2644,"interventions":2646},"NCT01905878","Biological Half Life of DLBS1033 in Healthy Volunteers",[80,81],"2013-12",14,[2645],"Healthy Condition",[2621],{"trials":2648,"activeCount":92},[],{"trials":2650,"activeCount":92},[],{"trials":2652,"activeCount":92},[],{"intervention":2654,"totalTrials":88,"cells":2655},"Insulin Glargine Pen Injector [Lantus]",{"EARLY_PHASE1":2656,"PHASE1":2658,"PHASE2":2660,"PHASE3":2680,"PHASE4":2682,"NA":2684},{"trials":2657,"activeCount":92},[],{"trials":2659,"activeCount":92},[],{"trials":2661,"activeCount":92},[2662,2671],{"nctId":2663,"briefTitle":2664,"status":102,"phases":2665,"primaryCompletion":2666,"completion":2666,"start":2667,"enrollment":815,"conditions":2668,"interventions":2669},"NCT03352674","Immunogenicity Study of Insulin Glargine Ezelin vs Lantus in Type 2 Diabetes Mellitus Patients",[81],"2018-12-01","2016-09",[32],[2670,2654],"Insulin Glargine Ezelin",{"nctId":2672,"briefTitle":2673,"status":406,"phases":2674,"primaryCompletion":2675,"completion":2675,"start":2676,"enrollment":342,"conditions":2677,"interventions":2678},"NCT04591457","The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus",[81],"2021-08","2020-10",[32],[2679,2654],"Insulin Glargine Sansulin",{"trials":2681,"activeCount":92},[],{"trials":2683,"activeCount":92},[],{"trials":2685,"activeCount":92},[],{"intervention":2687,"totalTrials":123,"cells":2688},"Continous Intravenous Lidocaine",{"EARLY_PHASE1":2689,"PHASE1":2691,"PHASE2":2693,"PHASE3":2703,"PHASE4":2705,"NA":2707},{"trials":2690,"activeCount":92},[],{"trials":2692,"activeCount":92},[],{"trials":2694,"activeCount":92},[2695],{"nctId":2696,"briefTitle":2697,"status":406,"phases":2698,"primaryCompletion":1598,"completion":1598,"start":2699,"enrollment":214,"conditions":2700,"interventions":2702},"NCT04773093","Effect of Continous Intravenous Lidocaine Infusion Intraoperative for Craniotomy Tumor Removal Surgery",[80,81],"2021-01-01",[2701],"Craniotomy Tumor Removal Surgery",[2687],{"trials":2704,"activeCount":92},[],{"trials":2706,"activeCount":92},[],{"trials":2708,"activeCount":92},[],{"intervention":2710,"totalTrials":123,"cells":2711},"Diquafosol sodium 3%",{"EARLY_PHASE1":2712,"PHASE1":2714,"PHASE2":2716,"PHASE3":2730,"PHASE4":2732,"NA":2734},{"trials":2713,"activeCount":92},[],{"trials":2715,"activeCount":92},[],{"trials":2717,"activeCount":92},[2718],{"nctId":2719,"briefTitle":2720,"status":406,"phases":2721,"primaryCompletion":2722,"completion":2723,"start":2724,"enrollment":2725,"conditions":2726,"interventions":2728},"NCT06146881","Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia",[81],"2023-12-15","2024-03-15","2022-10-02",70,[2727],"Dry Eye Disease",[2710,2729],"Sodium hyaluronate 0.1%",{"trials":2731,"activeCount":92},[],{"trials":2733,"activeCount":92},[],{"trials":2735,"activeCount":92},[],{"intervention":2729,"totalTrials":123,"cells":2737},{"EARLY_PHASE1":2738,"PHASE1":2740,"PHASE2":2742,"PHASE3":2748,"PHASE4":2750,"NA":2752},{"trials":2739,"activeCount":92},[],{"trials":2741,"activeCount":92},[],{"trials":2743,"activeCount":92},[2744],{"nctId":2719,"briefTitle":2720,"status":406,"phases":2745,"primaryCompletion":2722,"completion":2723,"start":2724,"enrollment":2725,"conditions":2746,"interventions":2747},[81],[2727],[2710,2729],{"trials":2749,"activeCount":92},[],{"trials":2751,"activeCount":92},[],{"trials":2753,"activeCount":92},[],{"intervention":2755,"totalTrials":123,"cells":2756},"Nigella sative",{"EARLY_PHASE1":2757,"PHASE1":2759,"PHASE2":2761,"PHASE3":2772,"PHASE4":2774,"NA":2776},{"trials":2758,"activeCount":92},[],{"trials":2760,"activeCount":92},[],{"trials":2762,"activeCount":92},[2763],{"nctId":2764,"briefTitle":2765,"status":102,"phases":2766,"primaryCompletion":1280,"completion":1280,"start":2767,"enrollment":2768,"conditions":2769,"interventions":2771},"NCT01531062","Effect of Nigella Sativa on Lipid Profiles in Elderly",[81],"2011-09",96,[2770],"Dyslipidemia",[2755],{"trials":2773,"activeCount":92},[],{"trials":2775,"activeCount":92},[],{"trials":2777,"activeCount":92},[],{"intervention":2779,"totalTrials":123,"cells":2780},"Rillus®",{"EARLY_PHASE1":2781,"PHASE1":2783,"PHASE2":2785,"PHASE3":2797,"PHASE4":2799,"NA":2801},{"trials":2782,"activeCount":92},[],{"trials":2784,"activeCount":92},[],{"trials":2786,"activeCount":92},[2787],{"nctId":2788,"briefTitle":2789,"status":102,"phases":2790,"primaryCompletion":2791,"completion":2791,"start":2792,"enrollment":434,"conditions":2793,"interventions":2796},"NCT03568812","The Role of Probiotics in HIV Patients With Immunological Non-Responder",[81],"2018-12-27","2018-05-07",[2794,2795],"HIV Infections","Immunological Abnormality",[2779],{"trials":2798,"activeCount":92},[],{"trials":2800,"activeCount":92},[],{"trials":2802,"activeCount":92},[],{"intervention":2804,"totalTrials":123,"cells":2805},"Ovine Enoxaparin",{"EARLY_PHASE1":2806,"PHASE1":2808,"PHASE2":2810,"PHASE3":2823,"PHASE4":2825,"NA":2827},{"trials":2807,"activeCount":92},[],{"trials":2809,"activeCount":92},[],{"trials":2811,"activeCount":92},[2812],{"nctId":2813,"briefTitle":2814,"status":102,"phases":2815,"primaryCompletion":2816,"completion":2817,"start":2818,"enrollment":1640,"conditions":2819,"interventions":2821},"NCT04402762","Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®",[80,81],"2020-04-17","2020-05-03","2019-12-20",[2820],"Enoxaparin",[2804,2822],"Enoxaparin Prefilled Syringe [Lovenox]",{"trials":2824,"activeCount":92},[],{"trials":2826,"activeCount":92},[],{"trials":2828,"activeCount":92},[],{"intervention":2822,"totalTrials":123,"cells":2830},{"EARLY_PHASE1":2831,"PHASE1":2833,"PHASE2":2835,"PHASE3":2841,"PHASE4":2843,"NA":2845},{"trials":2832,"activeCount":92},[],{"trials":2834,"activeCount":92},[],{"trials":2836,"activeCount":92},[2837],{"nctId":2813,"briefTitle":2814,"status":102,"phases":2838,"primaryCompletion":2816,"completion":2817,"start":2818,"enrollment":1640,"conditions":2839,"interventions":2840},[80,81],[2820],[2804,2822],{"trials":2842,"activeCount":92},[],{"trials":2844,"activeCount":92},[],{"trials":2846,"activeCount":92},[],{"intervention":2848,"totalTrials":123,"cells":2849},"low-dose",{"EARLY_PHASE1":2850,"PHASE1":2852,"PHASE2":2854,"PHASE3":2867,"PHASE4":2869,"NA":2871},{"trials":2851,"activeCount":92},[],{"trials":2853,"activeCount":92},[],{"trials":2855,"activeCount":92},[2856],{"nctId":2857,"briefTitle":2858,"status":102,"phases":2859,"primaryCompletion":2860,"completion":2861,"start":2421,"enrollment":2862,"conditions":2863,"interventions":2864},"NCT04557267","Dose-ranging Study of SKF7™ for Obesity",[81],"2021-05-20","2021-05-22",160,[15],[2848,2865,2866],"Middle-dose","Higher-dose",{"trials":2868,"activeCount":92},[],{"trials":2870,"activeCount":92},[],{"trials":2872,"activeCount":92},[],{"intervention":2865,"totalTrials":123,"cells":2874},{"EARLY_PHASE1":2875,"PHASE1":2877,"PHASE2":2879,"PHASE3":2885,"PHASE4":2887,"NA":2889},{"trials":2876,"activeCount":92},[],{"trials":2878,"activeCount":92},[],{"trials":2880,"activeCount":92},[2881],{"nctId":2857,"briefTitle":2858,"status":102,"phases":2882,"primaryCompletion":2860,"completion":2861,"start":2421,"enrollment":2862,"conditions":2883,"interventions":2884},[81],[15],[2848,2865,2866],{"trials":2886,"activeCount":92},[],{"trials":2888,"activeCount":92},[],{"trials":2890,"activeCount":92},[],{"intervention":2866,"totalTrials":123,"cells":2892},{"EARLY_PHASE1":2893,"PHASE1":2895,"PHASE2":2897,"PHASE3":2903,"PHASE4":2905,"NA":2907},{"trials":2894,"activeCount":92},[],{"trials":2896,"activeCount":92},[],{"trials":2898,"activeCount":92},[2899],{"nctId":2857,"briefTitle":2858,"status":102,"phases":2900,"primaryCompletion":2860,"completion":2861,"start":2421,"enrollment":2862,"conditions":2901,"interventions":2902},[81],[15],[2848,2865,2866],{"trials":2904,"activeCount":92},[],{"trials":2906,"activeCount":92},[],{"trials":2908,"activeCount":92},[],{"intervention":2670,"totalTrials":123,"cells":2910},{"EARLY_PHASE1":2911,"PHASE1":2913,"PHASE2":2915,"PHASE3":2921,"PHASE4":2923,"NA":2925},{"trials":2912,"activeCount":92},[],{"trials":2914,"activeCount":92},[],{"trials":2916,"activeCount":92},[2917],{"nctId":2663,"briefTitle":2664,"status":102,"phases":2918,"primaryCompletion":2666,"completion":2666,"start":2667,"enrollment":815,"conditions":2919,"interventions":2920},[81],[32],[2670,2654],{"trials":2922,"activeCount":92},[],{"trials":2924,"activeCount":92},[],{"trials":2926,"activeCount":92},[],{"intervention":2928,"totalTrials":123,"cells":2929},"Gabapentin",{"EARLY_PHASE1":2930,"PHASE1":2932,"PHASE2":2934,"PHASE3":2945,"PHASE4":2947,"NA":2949},{"trials":2931,"activeCount":92},[],{"trials":2933,"activeCount":92},[],{"trials":2935,"activeCount":92},[2936],{"nctId":2937,"briefTitle":2938,"status":102,"phases":2939,"primaryCompletion":2940,"completion":2940,"start":2941,"enrollment":940,"conditions":2942,"interventions":2944},"NCT04434430","Preemptive Oral Gabapentin 600 mg in Reducing Morphine Requirement After Non Obstetric Lower Abdominal Surgery",[80,81],"2020-02-29","2019-11-11",[2943],"Non-obstetric Lower Abdominal Surgery",[2928],{"trials":2946,"activeCount":92},[],{"trials":2948,"activeCount":92},[],{"trials":2950,"activeCount":92},[],{"intervention":2952,"totalTrials":123,"cells":2953},"Fosfomycin 3000 MG",{"EARLY_PHASE1":2954,"PHASE1":2956,"PHASE2":2958,"PHASE3":2971,"PHASE4":2973,"NA":2975},{"trials":2955,"activeCount":92},[],{"trials":2957,"activeCount":92},[],{"trials":2959,"activeCount":92},[2960],{"nctId":2961,"briefTitle":2962,"status":102,"phases":2963,"primaryCompletion":1843,"completion":1843,"start":2964,"enrollment":2965,"conditions":2966,"interventions":2969},"NCT06017479","Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention",[80,81],"2022-12-30",126,[2967,2968],"Urological System Complication of Procedure","Urinary Tract Infections",[2952,2970],"Levofloxacin 500mg",{"trials":2972,"activeCount":92},[],{"trials":2974,"activeCount":92},[],{"trials":2976,"activeCount":92},[],{"intervention":2970,"totalTrials":123,"cells":2978},{"EARLY_PHASE1":2979,"PHASE1":2981,"PHASE2":2983,"PHASE3":2989,"PHASE4":2991,"NA":2993},{"trials":2980,"activeCount":92},[],{"trials":2982,"activeCount":92},[],{"trials":2984,"activeCount":92},[2985],{"nctId":2961,"briefTitle":2962,"status":102,"phases":2986,"primaryCompletion":1843,"completion":1843,"start":2964,"enrollment":2965,"conditions":2987,"interventions":2988},[80,81],[2967,2968],[2952,2970],{"trials":2990,"activeCount":92},[],{"trials":2992,"activeCount":92},[],{"trials":2994,"activeCount":92},[],{"intervention":2996,"totalTrials":123,"cells":2997},"Bone-marrow aspiration, Intra-pancreatic Catheterisation of BM-MNC",{"EARLY_PHASE1":2998,"PHASE1":3000,"PHASE2":3002,"PHASE3":3014,"PHASE4":3016,"NA":3018},{"trials":2999,"activeCount":92},[],{"trials":3001,"activeCount":92},[],{"trials":3003,"activeCount":92},[3004],{"nctId":3005,"briefTitle":3006,"status":406,"phases":3007,"primaryCompletion":893,"completion":893,"start":3008,"enrollment":3009,"conditions":3010,"interventions":3012},"NCT04501341","BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients",[80,81],"2016-03-14",15,[3011],"T2D",[2996,3013],"Intravenous Infusion of UC-MSC",{"trials":3015,"activeCount":92},[],{"trials":3017,"activeCount":92},[],{"trials":3019,"activeCount":92},[],{"intervention":3013,"totalTrials":123,"cells":3021},{"EARLY_PHASE1":3022,"PHASE1":3024,"PHASE2":3026,"PHASE3":3032,"PHASE4":3034,"NA":3036},{"trials":3023,"activeCount":92},[],{"trials":3025,"activeCount":92},[],{"trials":3027,"activeCount":92},[3028],{"nctId":3005,"briefTitle":3006,"status":406,"phases":3029,"primaryCompletion":893,"completion":893,"start":3008,"enrollment":3009,"conditions":3030,"interventions":3031},[80,81],[3011],[2996,3013],{"trials":3033,"activeCount":92},[],{"trials":3035,"activeCount":92},[],{"trials":3037,"activeCount":92},[],{"intervention":3039,"totalTrials":123,"cells":3040},"Trigonella foenum-graceum extract topical cream",{"EARLY_PHASE1":3041,"PHASE1":3043,"PHASE2":3045,"PHASE3":3057,"PHASE4":3059,"NA":3061},{"trials":3042,"activeCount":92},[],{"trials":3044,"activeCount":92},[],{"trials":3046,"activeCount":92},[3047],{"nctId":3048,"briefTitle":3049,"status":102,"phases":3050,"primaryCompletion":3051,"completion":3052,"start":3053,"enrollment":2634,"conditions":3054,"interventions":3056},"NCT04123743","Efficacy of Extract of Trigonella Foenum-graceum as Topical Phytoestrogen in Skin Aging Treatment of Post Menopausal Women",[80,81],"2019-11-03","2019-11-10","2019-08-10",[3055],"Skin Aging",[3039],{"trials":3058,"activeCount":92},[],{"trials":3060,"activeCount":92},[],{"trials":3062,"activeCount":92},[],{"intervention":3064,"totalTrials":123,"cells":3065},"Cotrimoxazole",{"EARLY_PHASE1":3066,"PHASE1":3068,"PHASE2":3070,"PHASE3":3084,"PHASE4":3086,"NA":3088},{"trials":3067,"activeCount":92},[],{"trials":3069,"activeCount":92},[],{"trials":3071,"activeCount":92},[3072],{"nctId":3073,"briefTitle":3074,"status":406,"phases":3075,"primaryCompletion":3076,"completion":3076,"start":3077,"enrollment":2101,"conditions":3078,"interventions":3083},"NCT04985110","Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital",[81],"2023-07-06","2021-07-06",[3079,3080,3081,3082,2968,18],"Prostate Cancer","Prostate Biopsy","Perioperative Complication","Bacteriuria",[3064],{"trials":3085,"activeCount":92},[],{"trials":3087,"activeCount":92},[],{"trials":3089,"activeCount":92},[],{"intervention":3091,"totalTrials":123,"cells":3092},"retinoic acid cream 0.025%",{"EARLY_PHASE1":3093,"PHASE1":3095,"PHASE2":3097,"PHASE3":3109,"PHASE4":3111,"NA":3113},{"trials":3094,"activeCount":92},[],{"trials":3096,"activeCount":92},[],{"trials":3098,"activeCount":92},[3099],{"nctId":3100,"briefTitle":3101,"status":102,"phases":3102,"primaryCompletion":3103,"completion":2606,"start":3104,"enrollment":3105,"conditions":3106,"interventions":3107},"NCT07015931","Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V",[80,81],"2025-03-08","2024-11-30",23,[23],[3091,3108],"adapalene cream 0.1%",{"trials":3110,"activeCount":92},[],{"trials":3112,"activeCount":92},[],{"trials":3114,"activeCount":92},[],{"intervention":3108,"totalTrials":123,"cells":3116},{"EARLY_PHASE1":3117,"PHASE1":3119,"PHASE2":3121,"PHASE3":3127,"PHASE4":3129,"NA":3131},{"trials":3118,"activeCount":92},[],{"trials":3120,"activeCount":92},[],{"trials":3122,"activeCount":92},[3123],{"nctId":3100,"briefTitle":3101,"status":102,"phases":3124,"primaryCompletion":3103,"completion":2606,"start":3104,"enrollment":3105,"conditions":3125,"interventions":3126},[80,81],[23],[3091,3108],{"trials":3128,"activeCount":92},[],{"trials":3130,"activeCount":92},[],{"trials":3132,"activeCount":92},[],{"intervention":2679,"totalTrials":123,"cells":3134},{"EARLY_PHASE1":3135,"PHASE1":3137,"PHASE2":3139,"PHASE3":3145,"PHASE4":3147,"NA":3149},{"trials":3136,"activeCount":92},[],{"trials":3138,"activeCount":92},[],{"trials":3140,"activeCount":92},[3141],{"nctId":2672,"briefTitle":2673,"status":406,"phases":3142,"primaryCompletion":2675,"completion":2675,"start":2676,"enrollment":342,"conditions":3143,"interventions":3144},[81],[32],[2679,2654],{"trials":3146,"activeCount":92},[],{"trials":3148,"activeCount":92},[],{"trials":3150,"activeCount":92},[],{"intervention":3152,"totalTrials":123,"cells":3153},"Lemborexant",{"EARLY_PHASE1":3154,"PHASE1":3156,"PHASE2":3158,"PHASE3":3173,"PHASE4":3175,"NA":3177},{"trials":3155,"activeCount":92},[],{"trials":3157,"activeCount":92},[],{"trials":3159,"activeCount":92},[3160],{"nctId":3161,"briefTitle":3162,"status":102,"phases":3163,"primaryCompletion":3164,"completion":3164,"start":485,"enrollment":3165,"conditions":3166,"interventions":3172},"NCT07480096","Efficacy and Safety of Lemborexant for Patients With Cirrhosis and Sleep Problems",[81],"2025-10-30",82,[3167,3168,3169,3170,3171],"Cirrhosis","Liver Cirrhosis","Sleep Quality","Insomnia","Hepatic Encephalopathy",[3152],{"trials":3174,"activeCount":92},[],{"trials":3176,"activeCount":92},[],{"trials":3178,"activeCount":92},[],{"intervention":3180,"totalTrials":123,"cells":3181},"Dose of Neostigmine",{"EARLY_PHASE1":3182,"PHASE1":3184,"PHASE2":3186,"PHASE3":3198,"PHASE4":3200,"NA":3202},{"trials":3183,"activeCount":92},[],{"trials":3185,"activeCount":92},[],{"trials":3187,"activeCount":92},[3188],{"nctId":3189,"briefTitle":3190,"status":102,"phases":3191,"primaryCompletion":3192,"completion":3193,"start":1981,"enrollment":611,"conditions":3194,"interventions":3197},"NCT03058263","Effect of Neostigmine on the Recovery of Rocuronium: A Comparison Between Partial and TOF Ratio-Based Dose",[80,81],"2017-02-01","2017-02-28",[3195,3196],"Muscle Relaxant","General Anesthesia",[3180],{"trials":3199,"activeCount":92},[],{"trials":3201,"activeCount":92},[],{"trials":3203,"activeCount":92},[],{"intervention":3205,"totalTrials":123,"cells":3206},"Cholecalciferol 4000 IU Oral Capsule, Liquid Filled",{"EARLY_PHASE1":3207,"PHASE1":3209,"PHASE2":3211,"PHASE3":3222,"PHASE4":3224,"NA":3226},{"trials":3208,"activeCount":92},[],{"trials":3210,"activeCount":92},[],{"trials":3212,"activeCount":92},[3213],{"nctId":3214,"briefTitle":3215,"status":406,"phases":3216,"primaryCompletion":3217,"completion":3217,"start":3218,"enrollment":1483,"conditions":3219,"interventions":3221},"NCT04917458","Cholecalciferol on Depressive Symptoms in Type 2 Diabetes Mellitus Patients",[81],"2021-10","2021-01-18",[1105,3220],"Depressive Symptoms",[3205],{"trials":3223,"activeCount":92},[],{"trials":3225,"activeCount":92},[],{"trials":3227,"activeCount":92},[],{"intervention":3229,"totalTrials":123,"cells":3230},"Ondansetron 8 mg",{"EARLY_PHASE1":3231,"PHASE1":3233,"PHASE2":3235,"PHASE3":3245,"PHASE4":3247,"NA":3249},{"trials":3232,"activeCount":92},[],{"trials":3234,"activeCount":92},[],{"trials":3236,"activeCount":92},[3237],{"nctId":3238,"briefTitle":3239,"status":102,"phases":3240,"primaryCompletion":2667,"completion":2667,"start":762,"enrollment":487,"conditions":3241,"interventions":3243},"NCT03134612","Comparison Between Ondansetron 8 mg and Lidocain 40 mg in Preventing Pain Due to Propofol Injection",[81],[3242],"General Anesthesia With Propofol",[3229,3244],"Lidocain 40 mg",{"trials":3246,"activeCount":92},[],{"trials":3248,"activeCount":92},[],{"trials":3250,"activeCount":92},[],{"intervention":3244,"totalTrials":123,"cells":3252},{"EARLY_PHASE1":3253,"PHASE1":3255,"PHASE2":3257,"PHASE3":3263,"PHASE4":3265,"NA":3267},{"trials":3254,"activeCount":92},[],{"trials":3256,"activeCount":92},[],{"trials":3258,"activeCount":92},[3259],{"nctId":3238,"briefTitle":3239,"status":102,"phases":3260,"primaryCompletion":2667,"completion":2667,"start":762,"enrollment":487,"conditions":3261,"interventions":3262},[81],[3242],[3229,3244],{"trials":3264,"activeCount":92},[],{"trials":3266,"activeCount":92},[],{"trials":3268,"activeCount":92},[],{"intervention":3270,"totalTrials":123,"cells":3271},"Pre-urodynamic Levofloxacin",{"EARLY_PHASE1":3272,"PHASE1":3274,"PHASE2":3276,"PHASE3":3289,"PHASE4":3291,"NA":3293},{"trials":3273,"activeCount":92},[],{"trials":3275,"activeCount":92},[],{"trials":3277,"activeCount":92},[3278],{"nctId":3279,"briefTitle":3280,"status":102,"phases":3281,"primaryCompletion":3282,"completion":3283,"start":3284,"enrollment":3285,"conditions":3286,"interventions":3287},"NCT05219877","Effectiveness of Preurodynamic With Posturodynamic Levofloxacin on the Incidence of UTI",[80,81],"2022-04-03","2022-04-13","2022-02-04",134,[2968],[3270,3288],"Post-urodynamic Levofloxacin",{"trials":3290,"activeCount":92},[],{"trials":3292,"activeCount":92},[],{"trials":3294,"activeCount":92},[],{"intervention":3288,"totalTrials":123,"cells":3296},{"EARLY_PHASE1":3297,"PHASE1":3299,"PHASE2":3301,"PHASE3":3307,"PHASE4":3309,"NA":3311},{"trials":3298,"activeCount":92},[],{"trials":3300,"activeCount":92},[],{"trials":3302,"activeCount":92},[3303],{"nctId":3279,"briefTitle":3280,"status":102,"phases":3304,"primaryCompletion":3282,"completion":3283,"start":3284,"enrollment":3285,"conditions":3305,"interventions":3306},[80,81],[2968],[3270,3288],{"trials":3308,"activeCount":92},[],{"trials":3310,"activeCount":92},[],{"trials":3312,"activeCount":92},[],{"intervention":3314,"totalTrials":123,"cells":3315},"stem cells + hydroxy apatite",{"EARLY_PHASE1":3316,"PHASE1":3318,"PHASE2":3329,"PHASE3":3331,"PHASE4":3333,"NA":3335},{"trials":3317,"activeCount":92},[],{"trials":3319,"activeCount":92},[3320],{"nctId":3321,"briefTitle":3322,"status":406,"phases":3323,"primaryCompletion":761,"completion":3324,"start":3325,"enrollment":16,"conditions":3326,"interventions":3328},"NCT01626625","Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture",[80],"2016-01","2010-04",[3327],"Healing of Fracture",[3314],{"trials":3330,"activeCount":92},[],{"trials":3332,"activeCount":92},[],{"trials":3334,"activeCount":92},[],{"trials":3336,"activeCount":92},[],{"intervention":3338,"totalTrials":123,"cells":3339},"Doxycycline",{"EARLY_PHASE1":3340,"PHASE1":3342,"PHASE2":3354,"PHASE3":3356,"PHASE4":3358,"NA":3360},{"trials":3341,"activeCount":92},[],{"trials":3343,"activeCount":92},[3344],{"nctId":3345,"briefTitle":3346,"status":102,"phases":3347,"primaryCompletion":3348,"completion":3349,"start":3350,"enrollment":3351,"conditions":3352,"interventions":3353},"NCT04206631","Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris",[80],"2015-09-30","2015-10-14","2015-04-01",140,[23],[3338],{"trials":3355,"activeCount":92},[],{"trials":3357,"activeCount":92},[],{"trials":3359,"activeCount":92},[],{"trials":3361,"activeCount":92},[],{"intervention":3363,"totalTrials":123,"cells":3364},"olive oil",{"EARLY_PHASE1":3365,"PHASE1":3367,"PHASE2":3381,"PHASE3":3383,"PHASE4":3385,"NA":3387},{"trials":3366,"activeCount":92},[],{"trials":3368,"activeCount":92},[3369],{"nctId":3370,"briefTitle":3371,"status":102,"phases":3372,"primaryCompletion":3373,"completion":3374,"start":3375,"enrollment":16,"conditions":3376,"interventions":3379},"NCT03544411","Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM",[80],"2018-09-20","2018-10-05","2018-07-02",[1105,28,3377,3378],"Glucose, High Blood","Lipid Disorder",[3363,3380],"bran oil",{"trials":3382,"activeCount":92},[],{"trials":3384,"activeCount":92},[],{"trials":3386,"activeCount":92},[],{"trials":3388,"activeCount":92},[],{"intervention":3380,"totalTrials":123,"cells":3390},{"EARLY_PHASE1":3391,"PHASE1":3393,"PHASE2":3399,"PHASE3":3401,"PHASE4":3403,"NA":3405},{"trials":3392,"activeCount":92},[],{"trials":3394,"activeCount":92},[3395],{"nctId":3370,"briefTitle":3371,"status":102,"phases":3396,"primaryCompletion":3373,"completion":3374,"start":3375,"enrollment":16,"conditions":3397,"interventions":3398},[80],[1105,28,3377,3378],[3363,3380],{"trials":3400,"activeCount":92},[],{"trials":3402,"activeCount":92},[],{"trials":3404,"activeCount":92},[],{"trials":3406,"activeCount":92},[],{"intervention":3408,"totalTrials":123,"cells":3409},"Astaxanthine",{"EARLY_PHASE1":3410,"PHASE1":3412,"PHASE2":3425,"PHASE3":3427,"PHASE4":3429,"NA":3431},{"trials":3411,"activeCount":92},[],{"trials":3413,"activeCount":92},[3414],{"nctId":3415,"briefTitle":3416,"status":102,"phases":3417,"primaryCompletion":3418,"completion":3418,"start":3419,"enrollment":3420,"conditions":3421,"interventions":3424},"NCT03945526","Effect of Astaxanthin Supplementation on Plasma Malondialdehyde Levels and NIHSS of Stroke Patients",[80],"2010-06-09","2010-03-23",24,[3422,3423,28],"Cerebral Stroke","Malondialdehyde",[3408],{"trials":3426,"activeCount":92},[],{"trials":3428,"activeCount":92},[],{"trials":3430,"activeCount":92},[],{"trials":3432,"activeCount":92},[],{"intervention":3434,"totalTrials":123,"cells":3435},"Oseltamivir",{"EARLY_PHASE1":3436,"PHASE1":3438,"PHASE2":3453,"PHASE3":3455,"PHASE4":3457,"NA":3459},{"trials":3437,"activeCount":92},[],{"trials":3439,"activeCount":92},[3440],{"nctId":3441,"briefTitle":3442,"status":406,"phases":3443,"primaryCompletion":3444,"completion":3445,"start":3446,"enrollment":596,"conditions":3447,"interventions":3450},"NCT04457609","Administration of Allogenic UC-MSCs as Adjuvant Therapy for Critically-Ill COVID-19 Patients",[80],"2020-08","2020-09","2020-07",[1939,3448,3449],"Pulmonary Infection","Sars-CoV2",[3434,3451,3452],"Azithromycin","Umbilical Cord Mesenchymal Stem Cells",{"trials":3454,"activeCount":92},[],{"trials":3456,"activeCount":92},[],{"trials":3458,"activeCount":92},[],{"trials":3460,"activeCount":92},[],{"intervention":3451,"totalTrials":123,"cells":3462},{"EARLY_PHASE1":3463,"PHASE1":3465,"PHASE2":3471,"PHASE3":3473,"PHASE4":3475,"NA":3477},{"trials":3464,"activeCount":92},[],{"trials":3466,"activeCount":92},[3467],{"nctId":3441,"briefTitle":3442,"status":406,"phases":3468,"primaryCompletion":3444,"completion":3445,"start":3446,"enrollment":596,"conditions":3469,"interventions":3470},[80],[1939,3448,3449],[3434,3451,3452],{"trials":3472,"activeCount":92},[],{"trials":3474,"activeCount":92},[],{"trials":3476,"activeCount":92},[],{"trials":3478,"activeCount":92},[],{"intervention":3452,"totalTrials":123,"cells":3480},{"EARLY_PHASE1":3481,"PHASE1":3483,"PHASE2":3489,"PHASE3":3491,"PHASE4":3493,"NA":3495},{"trials":3482,"activeCount":92},[],{"trials":3484,"activeCount":92},[3485],{"nctId":3441,"briefTitle":3442,"status":406,"phases":3486,"primaryCompletion":3444,"completion":3445,"start":3446,"enrollment":596,"conditions":3487,"interventions":3488},[80],[1939,3448,3449],[3434,3451,3452],{"trials":3490,"activeCount":92},[],{"trials":3492,"activeCount":92},[],{"trials":3494,"activeCount":92},[],{"trials":3496,"activeCount":92},[],{"intervention":3498,"totalTrials":123,"cells":3499},"Moxifloxacin Ophthalmic Solution",{"EARLY_PHASE1":3500,"PHASE1":3502,"PHASE2":3514,"PHASE3":3516,"PHASE4":3518,"NA":3520},{"trials":3501,"activeCount":92},[],{"trials":3503,"activeCount":92},[3504],{"nctId":3505,"briefTitle":3506,"status":102,"phases":3507,"primaryCompletion":1912,"completion":1681,"start":3508,"enrollment":3509,"conditions":3510,"interventions":3512},"NCT05741632","Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery",[80],"2023-02-01",68,[3511],"Cataract",[3498,3513],"Levofloxacin Ophthalmic",{"trials":3515,"activeCount":92},[],{"trials":3517,"activeCount":92},[],{"trials":3519,"activeCount":92},[],{"trials":3521,"activeCount":92},[],{"intervention":3513,"totalTrials":123,"cells":3523},{"EARLY_PHASE1":3524,"PHASE1":3526,"PHASE2":3532,"PHASE3":3534,"PHASE4":3536,"NA":3538},{"trials":3525,"activeCount":92},[],{"trials":3527,"activeCount":92},[3528],{"nctId":3505,"briefTitle":3506,"status":102,"phases":3529,"primaryCompletion":1912,"completion":1681,"start":3508,"enrollment":3509,"conditions":3530,"interventions":3531},[80],[3511],[3498,3513],{"trials":3533,"activeCount":92},[],{"trials":3535,"activeCount":92},[],{"trials":3537,"activeCount":92},[],{"trials":3539,"activeCount":92},[],{"intervention":3541,"totalTrials":123,"cells":3542},"Mesenchymal stem cell, HA-CaSO4, ¬BMP-2, and Implant",{"EARLY_PHASE1":3543,"PHASE1":3545,"PHASE2":3557,"PHASE3":3559,"PHASE4":3561,"NA":3563},{"trials":3544,"activeCount":92},[],{"trials":3546,"activeCount":92},[3547],{"nctId":3548,"briefTitle":3549,"status":406,"phases":3550,"primaryCompletion":3551,"completion":3551,"start":3552,"enrollment":3553,"conditions":3554,"interventions":3556},"NCT01725698","The Combined Effect of Mesenchymal Stem Cell, HA-CaSO4,BMP-2, and Implant in Inducing The Healing of Critical-Sized Bone Defect",[80],"2014-12","2012-11",5,[3555],"Union",[3541],{"trials":3558,"activeCount":92},[],{"trials":3560,"activeCount":92},[],{"trials":3562,"activeCount":92},[],{"trials":3564,"activeCount":92},[],{"intervention":3566,"totalTrials":123,"cells":3567},"Amnion only",{"EARLY_PHASE1":3568,"PHASE1":3583,"PHASE2":3585,"PHASE3":3587,"PHASE4":3589,"NA":3591},{"trials":3569,"activeCount":92},[3570],{"nctId":3571,"briefTitle":3572,"status":406,"phases":3573,"primaryCompletion":3574,"completion":3575,"start":3576,"enrollment":596,"conditions":3577,"interventions":3579},"NCT04676269","Amnion Bilayer and Stem Cell Combination Therapy on Thin Endometrium Infertile Patients",[79],"2021-07-15","2021-12-15","2019-12-09",[3578],"Cell- and Tissue-Based Therapy",[3566,3580,3581,3582],"Amnion - endometrium cells","Amnion - amnion epithelial cells","Amnion-EnSC-AESC",{"trials":3584,"activeCount":92},[],{"trials":3586,"activeCount":92},[],{"trials":3588,"activeCount":92},[],{"trials":3590,"activeCount":92},[],{"trials":3592,"activeCount":92},[],{"intervention":3580,"totalTrials":123,"cells":3594},{"EARLY_PHASE1":3595,"PHASE1":3601,"PHASE2":3603,"PHASE3":3605,"PHASE4":3607,"NA":3609},{"trials":3596,"activeCount":92},[3597],{"nctId":3571,"briefTitle":3572,"status":406,"phases":3598,"primaryCompletion":3574,"completion":3575,"start":3576,"enrollment":596,"conditions":3599,"interventions":3600},[79],[3578],[3566,3580,3581,3582],{"trials":3602,"activeCount":92},[],{"trials":3604,"activeCount":92},[],{"trials":3606,"activeCount":92},[],{"trials":3608,"activeCount":92},[],{"trials":3610,"activeCount":92},[],{"intervention":3581,"totalTrials":123,"cells":3612},{"EARLY_PHASE1":3613,"PHASE1":3619,"PHASE2":3621,"PHASE3":3623,"PHASE4":3625,"NA":3627},{"trials":3614,"activeCount":92},[3615],{"nctId":3571,"briefTitle":3572,"status":406,"phases":3616,"primaryCompletion":3574,"completion":3575,"start":3576,"enrollment":596,"conditions":3617,"interventions":3618},[79],[3578],[3566,3580,3581,3582],{"trials":3620,"activeCount":92},[],{"trials":3622,"activeCount":92},[],{"trials":3624,"activeCount":92},[],{"trials":3626,"activeCount":92},[],{"trials":3628,"activeCount":92},[],{"intervention":3582,"totalTrials":123,"cells":3630},{"EARLY_PHASE1":3631,"PHASE1":3637,"PHASE2":3639,"PHASE3":3641,"PHASE4":3643,"NA":3645},{"trials":3632,"activeCount":92},[3633],{"nctId":3571,"briefTitle":3572,"status":406,"phases":3634,"primaryCompletion":3574,"completion":3575,"start":3576,"enrollment":596,"conditions":3635,"interventions":3636},[79],[3578],[3566,3580,3581,3582],{"trials":3638,"activeCount":92},[],{"trials":3640,"activeCount":92},[],{"trials":3642,"activeCount":92},[],{"trials":3644,"activeCount":92},[],{"trials":3646,"activeCount":92},[],{"intervention":3648,"totalTrials":123,"cells":3649},"Dienogest",{"EARLY_PHASE1":3650,"PHASE1":3662,"PHASE2":3664,"PHASE3":3666,"PHASE4":3668,"NA":3670},{"trials":3651,"activeCount":92},[3652],{"nctId":3653,"briefTitle":3654,"status":102,"phases":3655,"primaryCompletion":1937,"completion":1937,"start":3656,"enrollment":342,"conditions":3657,"interventions":3660},"NCT04374006","Effects of Sulawesi Propolis Extract on Lesion Growth, Apoptotic and Inflammatory Activity of the Rat Endometriosis Tissue",[79],"2019-11-01",[3658,3659],"Endometriosis; Peritoneum","Endometriosis",[3648,3661],"Propolis",{"trials":3663,"activeCount":92},[],{"trials":3665,"activeCount":92},[],{"trials":3667,"activeCount":92},[],{"trials":3669,"activeCount":92},[],{"trials":3671,"activeCount":92},[],{"intervention":3661,"totalTrials":123,"cells":3673},{"EARLY_PHASE1":3674,"PHASE1":3680,"PHASE2":3682,"PHASE3":3684,"PHASE4":3686,"NA":3688},{"trials":3675,"activeCount":92},[3676],{"nctId":3653,"briefTitle":3654,"status":102,"phases":3677,"primaryCompletion":1937,"completion":1937,"start":3656,"enrollment":342,"conditions":3678,"interventions":3679},[79],[3658,3659],[3648,3661],{"trials":3681,"activeCount":92},[],{"trials":3683,"activeCount":92},[],{"trials":3685,"activeCount":92},[],{"trials":3687,"activeCount":92},[],{"trials":3689,"activeCount":92},[],{"intervention":3691,"totalTrials":123,"cells":3692},"Artificial skin graft",{"EARLY_PHASE1":3693,"PHASE1":3706,"PHASE2":3708,"PHASE3":3710,"PHASE4":3712,"NA":3714},{"trials":3694,"activeCount":92},[3695],{"nctId":3696,"briefTitle":3697,"status":406,"phases":3698,"primaryCompletion":472,"completion":3699,"start":3700,"enrollment":1640,"conditions":3701,"interventions":3704},"NCT05652816","Biological Skin Graft With Keratinocyte-stem Cell Co-cultre for Burn Patients",[79],"2024-12-31","2022-09-06",[3702,3703],"Burn Degree Second","Burn Degree Third",[3691,3705],"Artificial skin graft co-culture",{"trials":3707,"activeCount":92},[],{"trials":3709,"activeCount":92},[],{"trials":3711,"activeCount":92},[],{"trials":3713,"activeCount":92},[],{"trials":3715,"activeCount":92},[],{"intervention":3705,"totalTrials":123,"cells":3717},{"EARLY_PHASE1":3718,"PHASE1":3724,"PHASE2":3726,"PHASE3":3728,"PHASE4":3730,"NA":3732},{"trials":3719,"activeCount":92},[3720],{"nctId":3696,"briefTitle":3697,"status":406,"phases":3721,"primaryCompletion":472,"completion":3699,"start":3700,"enrollment":1640,"conditions":3722,"interventions":3723},[79],[3702,3703],[3691,3705],{"trials":3725,"activeCount":92},[],{"trials":3727,"activeCount":92},[],{"trials":3729,"activeCount":92},[],{"trials":3731,"activeCount":92},[],{"trials":3733,"activeCount":92},[],{"intervention":3735,"totalTrials":123,"cells":3736},"Hyaluronic Acid",{"EARLY_PHASE1":3737,"PHASE1":3751,"PHASE2":3753,"PHASE3":3755,"PHASE4":3757,"NA":3759},{"trials":3738,"activeCount":92},[3739],{"nctId":3740,"briefTitle":3741,"status":406,"phases":3742,"primaryCompletion":3743,"completion":3743,"start":3744,"enrollment":3745,"conditions":3746,"interventions":3748},"NCT03800810","Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management",[79],"2019-05","2015-05",9,[3747],"Osteoarthritis, Knee",[3735,3749,3750],"Umbilical Cord Mesenchymal Stem Cell","Recombinant Human Somatropin",{"trials":3752,"activeCount":92},[],{"trials":3754,"activeCount":92},[],{"trials":3756,"activeCount":92},[],{"trials":3758,"activeCount":92},[],{"trials":3760,"activeCount":92},[],{"intervention":3749,"totalTrials":123,"cells":3762},{"EARLY_PHASE1":3763,"PHASE1":3769,"PHASE2":3771,"PHASE3":3773,"PHASE4":3775,"NA":3777},{"trials":3764,"activeCount":92},[3765],{"nctId":3740,"briefTitle":3741,"status":406,"phases":3766,"primaryCompletion":3743,"completion":3743,"start":3744,"enrollment":3745,"conditions":3767,"interventions":3768},[79],[3747],[3735,3749,3750],{"trials":3770,"activeCount":92},[],{"trials":3772,"activeCount":92},[],{"trials":3774,"activeCount":92},[],{"trials":3776,"activeCount":92},[],{"trials":3778,"activeCount":92},[],{"intervention":3750,"totalTrials":123,"cells":3780},{"EARLY_PHASE1":3781,"PHASE1":3787,"PHASE2":3789,"PHASE3":3791,"PHASE4":3793,"NA":3795},{"trials":3782,"activeCount":92},[3783],{"nctId":3740,"briefTitle":3741,"status":406,"phases":3784,"primaryCompletion":3743,"completion":3743,"start":3744,"enrollment":3745,"conditions":3785,"interventions":3786},[79],[3747],[3735,3749,3750],{"trials":3788,"activeCount":92},[],{"trials":3790,"activeCount":92},[],{"trials":3792,"activeCount":92},[],{"trials":3794,"activeCount":92},[],{"trials":3796,"activeCount":92},[],{"intervention":3798,"totalTrials":123,"cells":3799},"MSC",{"EARLY_PHASE1":3800,"PHASE1":3812,"PHASE2":3814,"PHASE3":3816,"PHASE4":3818,"NA":3820},{"trials":3801,"activeCount":92},[3802],{"nctId":3803,"briefTitle":3804,"status":406,"phases":3805,"primaryCompletion":3806,"completion":3806,"start":3807,"enrollment":3745,"conditions":3808,"interventions":3811},"NCT02307435","Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture",[79],"2017-12","2014-08",[3809,3810],"Non Union Fracture","Metaphyseal Fibrous Defect",[3798],{"trials":3813,"activeCount":92},[],{"trials":3815,"activeCount":92},[],{"trials":3817,"activeCount":92},[],{"trials":3819,"activeCount":92},[],{"trials":3821,"activeCount":92},[],{"intervention":3823,"totalTrials":88,"cells":3824},"Propofol",{"EARLY_PHASE1":3825,"PHASE1":3827,"PHASE2":3829,"PHASE3":3831,"PHASE4":3833,"NA":3835},{"trials":3826,"activeCount":92},[],{"trials":3828,"activeCount":92},[],{"trials":3830,"activeCount":92},[],{"trials":3832,"activeCount":92},[],{"trials":3834,"activeCount":92},[],{"trials":3836,"activeCount":92},[3837,3847],{"nctId":3838,"briefTitle":3839,"status":102,"phases":3840,"primaryCompletion":3841,"completion":3841,"start":3842,"enrollment":3843,"conditions":3844,"interventions":3846},"NCT03528954","Propofol to Reduce the Incidence of Postanesthetic Emergence Agitation in Pediatric Patients Under General Anesthesia",[84],"2018-08-31","2018-05-31",54,[3845],"Pediatric ALL",[3823],{"nctId":3848,"briefTitle":3849,"status":102,"phases":3850,"primaryCompletion":3851,"completion":3852,"start":3853,"enrollment":3105,"conditions":3854,"interventions":3856},"NCT03214653","Comparison Between Target-controlled Infusion of Propofol and Sevoflurane as Maintenance of Anesthesia to Hemodynamic Profile of Renal Transplant Recipient",[84],"2017-11-30","2018-01-31","2017-07-01",[3855],"Renal Transplant Recipient Patients",[3823,3857],"Sevoflurane",{"intervention":3859,"totalTrials":88,"cells":3860},"Tranexamic acid",{"EARLY_PHASE1":3861,"PHASE1":3863,"PHASE2":3865,"PHASE3":3867,"PHASE4":3869,"NA":3871},{"trials":3862,"activeCount":92},[],{"trials":3864,"activeCount":92},[],{"trials":3866,"activeCount":92},[],{"trials":3868,"activeCount":92},[],{"trials":3870,"activeCount":92},[],{"trials":3872,"activeCount":92},[3873,3881],{"nctId":3874,"briefTitle":3875,"status":102,"phases":3876,"primaryCompletion":939,"completion":3877,"start":421,"enrollment":1211,"conditions":3878,"interventions":3880},"NCT03540368","Tranexamic Acid for The Treatment of Gastrointestinal Bleeding",[84],"2019-12-31",[3879],"Gastrointestinal Bleeding",[3859],{"nctId":3882,"briefTitle":3883,"status":102,"phases":3884,"primaryCompletion":3885,"completion":3885,"start":3886,"enrollment":281,"conditions":3887,"interventions":3888},"NCT05236569","Effectiveness and Safety of Intradermal Tranexamic Acid Injection as An Adjunctive Treatment for Melasma in Skin Type IV - V",[84],"2021-05-31","2021-02-01",[283],[3859,3889],"Injection Water",{"intervention":3891,"totalTrials":123,"cells":3892},"Tretinoin",{"EARLY_PHASE1":3893,"PHASE1":3895,"PHASE2":3897,"PHASE3":3899,"PHASE4":3901,"NA":3903},{"trials":3894,"activeCount":92},[],{"trials":3896,"activeCount":92},[],{"trials":3898,"activeCount":92},[],{"trials":3900,"activeCount":92},[],{"trials":3902,"activeCount":92},[],{"trials":3904,"activeCount":92},[3905],{"nctId":3906,"briefTitle":3907,"status":406,"phases":3908,"primaryCompletion":3909,"completion":3910,"start":3911,"enrollment":596,"conditions":3912,"interventions":3913},"NCT06181838","Comparison of Quality of Life in Moderate Acne Vulgaris Patients Based on Acne-QoL-INA Using Standard Therapy With and Without Acne Lesions Extraction",[84],"2023-11-24","2024-01-03","2023-08-28",[23,26],[3891],{"intervention":3915,"totalTrials":123,"cells":3916},"COVID-19 Vaccine",{"EARLY_PHASE1":3917,"PHASE1":3919,"PHASE2":3921,"PHASE3":3923,"PHASE4":3925,"NA":3927},{"trials":3918,"activeCount":92},[],{"trials":3920,"activeCount":92},[],{"trials":3922,"activeCount":92},[],{"trials":3924,"activeCount":92},[],{"trials":3926,"activeCount":92},[],{"trials":3928,"activeCount":92},[3929],{"nctId":3930,"briefTitle":3931,"status":406,"phases":3932,"primaryCompletion":3933,"completion":3934,"start":3935,"enrollment":3936,"conditions":3937,"interventions":3939},"NCT05587868","COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients",[],"2022-11","2023-05","2022-03-11",250,[2469,3938],"SARS CoV-2 Infection",[3915],{"intervention":3941,"totalTrials":123,"cells":3942},"Ibuprofen",{"EARLY_PHASE1":3943,"PHASE1":3945,"PHASE2":3947,"PHASE3":3949,"PHASE4":3951,"NA":3953},{"trials":3944,"activeCount":92},[],{"trials":3946,"activeCount":92},[],{"trials":3948,"activeCount":92},[],{"trials":3950,"activeCount":92},[],{"trials":3952,"activeCount":92},[],{"trials":3954,"activeCount":92},[3955],{"nctId":3956,"briefTitle":3957,"status":102,"phases":3958,"primaryCompletion":3851,"completion":3851,"start":3853,"enrollment":3959,"conditions":3960,"interventions":3963},"NCT03771755","Ibuprofen IV vs Acetaminophen IV for the Treatment of Pain Following Orthopaedic Low Extremity Surgery",[84],62,[3961,21,3962],"Lower Extremity Problem","Postoperative Pain",[3941,3964],"Acetaminophen",{"intervention":3964,"totalTrials":123,"cells":3966},{"EARLY_PHASE1":3967,"PHASE1":3969,"PHASE2":3971,"PHASE3":3973,"PHASE4":3975,"NA":3977},{"trials":3968,"activeCount":92},[],{"trials":3970,"activeCount":92},[],{"trials":3972,"activeCount":92},[],{"trials":3974,"activeCount":92},[],{"trials":3976,"activeCount":92},[],{"trials":3978,"activeCount":92},[3979],{"nctId":3956,"briefTitle":3957,"status":102,"phases":3980,"primaryCompletion":3851,"completion":3851,"start":3853,"enrollment":3959,"conditions":3981,"interventions":3982},[84],[3961,21,3962],[3941,3964],{"intervention":3984,"totalTrials":123,"cells":3985},"Bilateral QL block",{"EARLY_PHASE1":3986,"PHASE1":3988,"PHASE2":3990,"PHASE3":3992,"PHASE4":3994,"NA":3996},{"trials":3987,"activeCount":92},[],{"trials":3989,"activeCount":92},[],{"trials":3991,"activeCount":92},[],{"trials":3993,"activeCount":92},[],{"trials":3995,"activeCount":92},[],{"trials":3997,"activeCount":92},[3998],{"nctId":3999,"briefTitle":4000,"status":102,"phases":4001,"primaryCompletion":4002,"completion":4003,"start":4004,"enrollment":4005,"conditions":4006,"interventions":4007},"NCT03879980","Effect of Quadratus Lumborum Block on Perioperative Analgesia and Inflammatory Responses in Laparoscopic Nephrectomy",[84],"2019-05-13","2019-06-17","2019-03-18",44,[3962],[3984,4008],"Non-QL block",{"intervention":4008,"totalTrials":123,"cells":4010},{"EARLY_PHASE1":4011,"PHASE1":4013,"PHASE2":4015,"PHASE3":4017,"PHASE4":4019,"NA":4021},{"trials":4012,"activeCount":92},[],{"trials":4014,"activeCount":92},[],{"trials":4016,"activeCount":92},[],{"trials":4018,"activeCount":92},[],{"trials":4020,"activeCount":92},[],{"trials":4022,"activeCount":92},[4023],{"nctId":3999,"briefTitle":4000,"status":102,"phases":4024,"primaryCompletion":4002,"completion":4003,"start":4004,"enrollment":4005,"conditions":4025,"interventions":4026},[84],[3962],[3984,4008],{"intervention":4028,"totalTrials":123,"cells":4029},"Propofol and Ketamine Mixture",{"EARLY_PHASE1":4030,"PHASE1":4032,"PHASE2":4034,"PHASE3":4036,"PHASE4":4038,"NA":4040},{"trials":4031,"activeCount":92},[],{"trials":4033,"activeCount":92},[],{"trials":4035,"activeCount":92},[],{"trials":4037,"activeCount":92},[],{"trials":4039,"activeCount":92},[],{"trials":4041,"activeCount":92},[4042],{"nctId":4043,"briefTitle":4044,"status":102,"phases":4045,"primaryCompletion":4046,"completion":4047,"start":4048,"enrollment":4049,"conditions":4050,"interventions":4051},"NCT04029831","Comparison of Different Ratio of Ketofol (6:1 vs. 4:1) for Sedation in Endoscopic Retrograde Cholangiopancreatography (ERCP)",[84],"2017-05-01","2017-06-01","2017-03-01",58,[2362],[4028],{"intervention":4053,"totalTrials":123,"cells":4054},"lidocaine gel",{"EARLY_PHASE1":4055,"PHASE1":4057,"PHASE2":4059,"PHASE3":4061,"PHASE4":4063,"NA":4065},{"trials":4056,"activeCount":92},[],{"trials":4058,"activeCount":92},[],{"trials":4060,"activeCount":92},[],{"trials":4062,"activeCount":92},[],{"trials":4064,"activeCount":92},[],{"trials":4066,"activeCount":92},[4067],{"nctId":4068,"briefTitle":4069,"status":102,"phases":4070,"primaryCompletion":4071,"completion":3852,"start":4072,"enrollment":940,"conditions":4073,"interventions":4075},"NCT03143452","Comparison Between 2% Lidocaine Gel and 5% Tetracaine Eye Drop as Topical Anesthesia in Phacoemulsification",[84],"2017-12-01","2016-12-01",[4074],"Adult Patients Undergoing Phacoemulsification With Topical Anesthesia",[4053,4076],"tetracaine eye drop",{"intervention":4076,"totalTrials":123,"cells":4078},{"EARLY_PHASE1":4079,"PHASE1":4081,"PHASE2":4083,"PHASE3":4085,"PHASE4":4087,"NA":4089},{"trials":4080,"activeCount":92},[],{"trials":4082,"activeCount":92},[],{"trials":4084,"activeCount":92},[],{"trials":4086,"activeCount":92},[],{"trials":4088,"activeCount":92},[],{"trials":4090,"activeCount":92},[4091],{"nctId":4068,"briefTitle":4069,"status":102,"phases":4092,"primaryCompletion":4071,"completion":3852,"start":4072,"enrollment":940,"conditions":4093,"interventions":4094},[84],[4074],[4053,4076],{"intervention":4096,"totalTrials":123,"cells":4097},"Calcium Carbonate",{"EARLY_PHASE1":4098,"PHASE1":4100,"PHASE2":4102,"PHASE3":4104,"PHASE4":4106,"NA":4108},{"trials":4099,"activeCount":92},[],{"trials":4101,"activeCount":92},[],{"trials":4103,"activeCount":92},[],{"trials":4105,"activeCount":92},[],{"trials":4107,"activeCount":92},[],{"trials":4109,"activeCount":92},[4110],{"nctId":4111,"briefTitle":4112,"status":102,"phases":4113,"primaryCompletion":4114,"completion":4114,"start":4115,"enrollment":4116,"conditions":4117,"interventions":4119},"NCT03550534","The Effectiveness and Safety of Calcium Carbonate in Chronic Kidney Disease With Normophosphatemia",[84],"2016-12-11","2015-11-06",46,[4118],"Chronic Kidney Diseases",[4096],{"intervention":4121,"totalTrials":123,"cells":4122},"Calcitriol",{"EARLY_PHASE1":4123,"PHASE1":4125,"PHASE2":4127,"PHASE3":4129,"PHASE4":4131,"NA":4133},{"trials":4124,"activeCount":92},[],{"trials":4126,"activeCount":92},[],{"trials":4128,"activeCount":92},[],{"trials":4130,"activeCount":92},[],{"trials":4132,"activeCount":92},[],{"trials":4134,"activeCount":92},[4135],{"nctId":4136,"briefTitle":4137,"status":406,"phases":4138,"primaryCompletion":4139,"completion":4140,"start":4141,"enrollment":342,"conditions":4142,"interventions":4144},"NCT05298163","The Effects of Calcitriol on Biomarkers in Diabetic Kidney Disease Patients",[84],"2022-10","2022-12","2022-04",[4143],"Diabetic Kidney Disease",[4121],{"intervention":3857,"totalTrials":123,"cells":4146},{"EARLY_PHASE1":4147,"PHASE1":4149,"PHASE2":4151,"PHASE3":4153,"PHASE4":4155,"NA":4157},{"trials":4148,"activeCount":92},[],{"trials":4150,"activeCount":92},[],{"trials":4152,"activeCount":92},[],{"trials":4154,"activeCount":92},[],{"trials":4156,"activeCount":92},[],{"trials":4158,"activeCount":92},[4159],{"nctId":3848,"briefTitle":3849,"status":102,"phases":4160,"primaryCompletion":3851,"completion":3852,"start":3853,"enrollment":3105,"conditions":4161,"interventions":4162},[84],[3855],[3823,3857],{"intervention":4164,"totalTrials":123,"cells":4165},"Sodium Fusidate 2 % Topical Ointment",{"EARLY_PHASE1":4166,"PHASE1":4168,"PHASE2":4170,"PHASE3":4172,"PHASE4":4174,"NA":4176},{"trials":4167,"activeCount":92},[],{"trials":4169,"activeCount":92},[],{"trials":4171,"activeCount":92},[],{"trials":4173,"activeCount":92},[],{"trials":4175,"activeCount":92},[],{"trials":4177,"activeCount":92},[4178],{"nctId":4179,"briefTitle":4180,"status":102,"phases":4181,"primaryCompletion":3885,"completion":3885,"start":2699,"enrollment":4182,"conditions":4183,"interventions":4186},"NCT05353374","Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization",[84],22,[4184,4185],"Seborrheic Keratosis","Acrochordon",[4164,4187],"Petrolatum ointment",{"intervention":4187,"totalTrials":123,"cells":4189},{"EARLY_PHASE1":4190,"PHASE1":4192,"PHASE2":4194,"PHASE3":4196,"PHASE4":4198,"NA":4200},{"trials":4191,"activeCount":92},[],{"trials":4193,"activeCount":92},[],{"trials":4195,"activeCount":92},[],{"trials":4197,"activeCount":92},[],{"trials":4199,"activeCount":92},[],{"trials":4201,"activeCount":92},[4202],{"nctId":4179,"briefTitle":4180,"status":102,"phases":4203,"primaryCompletion":3885,"completion":3885,"start":2699,"enrollment":4182,"conditions":4204,"interventions":4205},[84],[4184,4185],[4164,4187],{"intervention":4207,"totalTrials":123,"cells":4208},"NaCl 0.9%",{"EARLY_PHASE1":4209,"PHASE1":4211,"PHASE2":4213,"PHASE3":4215,"PHASE4":4217,"NA":4219},{"trials":4210,"activeCount":92},[],{"trials":4212,"activeCount":92},[],{"trials":4214,"activeCount":92},[],{"trials":4216,"activeCount":92},[],{"trials":4218,"activeCount":92},[],{"trials":4220,"activeCount":92},[4221],{"nctId":4222,"briefTitle":4223,"status":102,"phases":4224,"primaryCompletion":4225,"completion":4226,"start":4227,"enrollment":182,"conditions":4228,"interventions":4231},"NCT06249113","Effectiveness of Continous Adjuvant Lidocaine on General Anaesthesia on Tumor Craniotomy Surgery",[84],"2023-11-23","2024-01-10","2023-01-16",[21,4229,4230],"Anesthesia; Functional","Haemodynamic Instability",[4207,4232],"Adjuvant lidocaine continous",{"intervention":4232,"totalTrials":123,"cells":4234},{"EARLY_PHASE1":4235,"PHASE1":4237,"PHASE2":4239,"PHASE3":4241,"PHASE4":4243,"NA":4245},{"trials":4236,"activeCount":92},[],{"trials":4238,"activeCount":92},[],{"trials":4240,"activeCount":92},[],{"trials":4242,"activeCount":92},[],{"trials":4244,"activeCount":92},[],{"trials":4246,"activeCount":92},[4247],{"nctId":4222,"briefTitle":4223,"status":102,"phases":4248,"primaryCompletion":4225,"completion":4226,"start":4227,"enrollment":182,"conditions":4249,"interventions":4250},[84],[21,4229,4230],[4207,4232],{"intervention":4252,"totalTrials":123,"cells":4253},"Cyclosporin",{"EARLY_PHASE1":4254,"PHASE1":4256,"PHASE2":4258,"PHASE3":4260,"PHASE4":4262,"NA":4264},{"trials":4255,"activeCount":92},[],{"trials":4257,"activeCount":92},[],{"trials":4259,"activeCount":92},[],{"trials":4261,"activeCount":92},[],{"trials":4263,"activeCount":92},[],{"trials":4265,"activeCount":92},[4266],{"nctId":4267,"briefTitle":4268,"status":102,"phases":4269,"primaryCompletion":893,"completion":4270,"start":2536,"enrollment":596,"conditions":4271,"interventions":4274},"NCT05691764","Effect of Cyclosporine and Remote Ischemic Preconditioning in Reperfusion Ischemia Injury on Tetralogy Fallot Patients With Correction Surgery",[84],"2022-09-01",[4272,4273],"Myocardial Injury","Cardiac Surgery",[4252],{"intervention":4276,"totalTrials":123,"cells":4277},"Bupivacaine-fentanyl",{"EARLY_PHASE1":4278,"PHASE1":4280,"PHASE2":4282,"PHASE3":4284,"PHASE4":4286,"NA":4288},{"trials":4279,"activeCount":92},[],{"trials":4281,"activeCount":92},[],{"trials":4283,"activeCount":92},[],{"trials":4285,"activeCount":92},[],{"trials":4287,"activeCount":92},[],{"trials":4289,"activeCount":92},[4290],{"nctId":4291,"briefTitle":4292,"status":102,"phases":4293,"primaryCompletion":4294,"completion":3842,"start":4295,"enrollment":1844,"conditions":4296,"interventions":4298},"NCT03693638","Fractionated Vs Single Dose Injection for Spinal C-Section in Patients With Pregnancy-Induced Hypertension",[84],"2018-04-30","2018-01-01",[4297],"Pregnancy Induced Hypertension",[4276,4276],{"intervention":4300,"totalTrials":123,"cells":4301},"cyproheptadine hydrochloride",{"EARLY_PHASE1":4302,"PHASE1":4304,"PHASE2":4306,"PHASE3":4308,"PHASE4":4310,"NA":4312},{"trials":4303,"activeCount":92},[],{"trials":4305,"activeCount":92},[],{"trials":4307,"activeCount":92},[],{"trials":4309,"activeCount":92},[],{"trials":4311,"activeCount":92},[],{"trials":4313,"activeCount":92},[4314],{"nctId":4315,"briefTitle":4316,"status":102,"phases":4317,"primaryCompletion":4318,"completion":4319,"start":4320,"enrollment":4005,"conditions":4321,"interventions":4323},"NCT07006181","Effectiveness of Cyproheptadine Hydrochloride Against Appetite to Improve Children's Nutritional Status",[84],"2025-02-28","2025-03-31","2024-11-04",[4322],"Appetite Loss",[4300],{"intervention":4325,"totalTrials":123,"cells":4326},"Autologous Adipose Mesenchymal Stem Cell Implantation",{"EARLY_PHASE1":4327,"PHASE1":4329,"PHASE2":4331,"PHASE3":4333,"PHASE4":4335,"NA":4337},{"trials":4328,"activeCount":92},[],{"trials":4330,"activeCount":92},[],{"trials":4332,"activeCount":92},[],{"trials":4334,"activeCount":92},[],{"trials":4336,"activeCount":92},[],{"trials":4338,"activeCount":92},[4339],{"nctId":4340,"briefTitle":4341,"status":406,"phases":4342,"primaryCompletion":4343,"completion":4343,"start":4344,"enrollment":3009,"conditions":4345,"interventions":4349},"NCT04876326","Potential Use of Autologous and Allogeneic Mesenchymal Stem Cells in Patients With Multiple System Atrophy",[84],"2021-10-05","2020-10-05",[4346,4347,4348],"Multiple System Atrophy","Parkinsonism","Multiple System Atrophy, Parkinson Variant",[4325,4350,4351],"Allogeneic Umbilical Cord Mesenchymal Stem Cell Implantation","Allogeneic Umbilical Cord Mesenchymal Stem Cell and Adipose Secretome Implantation",{"intervention":4350,"totalTrials":123,"cells":4353},{"EARLY_PHASE1":4354,"PHASE1":4356,"PHASE2":4358,"PHASE3":4360,"PHASE4":4362,"NA":4364},{"trials":4355,"activeCount":92},[],{"trials":4357,"activeCount":92},[],{"trials":4359,"activeCount":92},[],{"trials":4361,"activeCount":92},[],{"trials":4363,"activeCount":92},[],{"trials":4365,"activeCount":92},[4366],{"nctId":4340,"briefTitle":4341,"status":406,"phases":4367,"primaryCompletion":4343,"completion":4343,"start":4344,"enrollment":3009,"conditions":4368,"interventions":4369},[84],[4346,4347,4348],[4325,4350,4351],{"intervention":4351,"totalTrials":123,"cells":4371},{"EARLY_PHASE1":4372,"PHASE1":4374,"PHASE2":4376,"PHASE3":4378,"PHASE4":4380,"NA":4382},{"trials":4373,"activeCount":92},[],{"trials":4375,"activeCount":92},[],{"trials":4377,"activeCount":92},[],{"trials":4379,"activeCount":92},[],{"trials":4381,"activeCount":92},[],{"trials":4383,"activeCount":92},[4384],{"nctId":4340,"briefTitle":4341,"status":406,"phases":4385,"primaryCompletion":4343,"completion":4343,"start":4344,"enrollment":3009,"conditions":4386,"interventions":4387},[84],[4346,4347,4348],[4325,4350,4351],{"intervention":4389,"totalTrials":123,"cells":4390},"Dexamethasone 8 mg",{"EARLY_PHASE1":4391,"PHASE1":4393,"PHASE2":4395,"PHASE3":4397,"PHASE4":4399,"NA":4401},{"trials":4392,"activeCount":92},[],{"trials":4394,"activeCount":92},[],{"trials":4396,"activeCount":92},[],{"trials":4398,"activeCount":92},[],{"trials":4400,"activeCount":92},[],{"trials":4402,"activeCount":92},[4403],{"nctId":4404,"briefTitle":4405,"status":102,"phases":4406,"primaryCompletion":4407,"completion":4408,"start":4409,"enrollment":143,"conditions":4410,"interventions":4412},"NCT03051022","Comparison Between Dexamethasone and Morphine as an Adjuvant to Bupivacaine for Post-operative Analgesia",[84],"2016-11-30","2017-03-31","2016-05-01",[4411],"Lower Extremities Fracture",[4389,4413],"Morphine 2 mg",{"intervention":4413,"totalTrials":123,"cells":4415},{"EARLY_PHASE1":4416,"PHASE1":4418,"PHASE2":4420,"PHASE3":4422,"PHASE4":4424,"NA":4426},{"trials":4417,"activeCount":92},[],{"trials":4419,"activeCount":92},[],{"trials":4421,"activeCount":92},[],{"trials":4423,"activeCount":92},[],{"trials":4425,"activeCount":92},[],{"trials":4427,"activeCount":92},[4428],{"nctId":4404,"briefTitle":4405,"status":102,"phases":4429,"primaryCompletion":4407,"completion":4408,"start":4409,"enrollment":143,"conditions":4430,"interventions":4431},[84],[4411],[4389,4413],{"intervention":4433,"totalTrials":123,"cells":4434},"propranolol 20mg",{"EARLY_PHASE1":4435,"PHASE1":4437,"PHASE2":4439,"PHASE3":4441,"PHASE4":4443,"NA":4445},{"trials":4436,"activeCount":92},[],{"trials":4438,"activeCount":92},[],{"trials":4440,"activeCount":92},[],{"trials":4442,"activeCount":92},[],{"trials":4444,"activeCount":92},[],{"trials":4446,"activeCount":92},[4447],{"nctId":4448,"briefTitle":4449,"status":102,"phases":4450,"primaryCompletion":4451,"completion":4452,"start":213,"enrollment":1683,"conditions":4453,"interventions":4455},"NCT07067853","Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients",[84],"2025-12-01","2025-12-15",[4454],"Migraine",[4433],{"intervention":4457,"totalTrials":123,"cells":4458},"ketamine and propofol mixture with 1:6 ratio",{"EARLY_PHASE1":4459,"PHASE1":4461,"PHASE2":4463,"PHASE3":4465,"PHASE4":4467,"NA":4469},{"trials":4460,"activeCount":92},[],{"trials":4462,"activeCount":92},[],{"trials":4464,"activeCount":92},[],{"trials":4466,"activeCount":92},[],{"trials":4468,"activeCount":92},[],{"trials":4470,"activeCount":92},[4471],{"nctId":4472,"briefTitle":4473,"status":102,"phases":4474,"primaryCompletion":4475,"completion":4476,"start":4048,"enrollment":4049,"conditions":4477,"interventions":4479},"NCT03196479","Comparison Between Efficacy of Ketamine and Propofol Mixture With 1:6 Ratio and 1:4 Ratio for Endoscopic Retrograde Procedure Sedation",[84],"2017-06-30","2017-08-31",[4478],"Adult Patients Undergoing ERCP",[4457,4480],"ketamine and propofol mixture with 1:4 ratio",{"intervention":4480,"totalTrials":123,"cells":4482},{"EARLY_PHASE1":4483,"PHASE1":4485,"PHASE2":4487,"PHASE3":4489,"PHASE4":4491,"NA":4493},{"trials":4484,"activeCount":92},[],{"trials":4486,"activeCount":92},[],{"trials":4488,"activeCount":92},[],{"trials":4490,"activeCount":92},[],{"trials":4492,"activeCount":92},[],{"trials":4494,"activeCount":92},[4495],{"nctId":4472,"briefTitle":4473,"status":102,"phases":4496,"primaryCompletion":4475,"completion":4476,"start":4048,"enrollment":4049,"conditions":4497,"interventions":4498},[84],[4478],[4457,4480],{"intervention":4500,"totalTrials":123,"cells":4501},"Intranasal dexmedetomidine at dose of 2 mcg\u002Fkg and 4 mcg\u002Fkg",{"EARLY_PHASE1":4502,"PHASE1":4504,"PHASE2":4506,"PHASE3":4508,"PHASE4":4510,"NA":4512},{"trials":4503,"activeCount":92},[],{"trials":4505,"activeCount":92},[],{"trials":4507,"activeCount":92},[],{"trials":4509,"activeCount":92},[],{"trials":4511,"activeCount":92},[],{"trials":4513,"activeCount":92},[4514],{"nctId":4515,"briefTitle":4516,"status":102,"phases":4517,"primaryCompletion":4518,"completion":1100,"start":4519,"enrollment":4520,"conditions":4521,"interventions":4524},"NCT05091151","Intranasal Dexmedetomidine Sedation at Dose of 2 mcg\u002Fkg Versus 4 mcg\u002Fkg in Children Undergoing MRI",[84],"2019-04-30","2019-02-01",94,[30,4522,4523,3845],"Deep Sedation","Magnetic Resonance Imaging",[4500],{"intervention":4526,"totalTrials":123,"cells":4527},"Mixture of local anesthetics",{"EARLY_PHASE1":4528,"PHASE1":4530,"PHASE2":4532,"PHASE3":4534,"PHASE4":4536,"NA":4538},{"trials":4529,"activeCount":92},[],{"trials":4531,"activeCount":92},[],{"trials":4533,"activeCount":92},[],{"trials":4535,"activeCount":92},[],{"trials":4537,"activeCount":92},[],{"trials":4539,"activeCount":92},[4540],{"nctId":4541,"briefTitle":4542,"status":102,"phases":4543,"primaryCompletion":4544,"completion":4544,"start":4545,"enrollment":4546,"conditions":4547,"interventions":4552},"NCT06702202","Effect of Subarachnoid Block and Femoropopliteal Block to Limb Perfusion in PAD Patients",[84],"2024-07-01","2024-01-01",16,[4548,4549,4550,4551],"Peripheral Arterial Disease","Subarachnoid Block","Femoropopliteal Block","Tissue Oxygen Saturation",[4526,4553],"0.5% hyperbaric bupivacaine",{"intervention":4553,"totalTrials":123,"cells":4555},{"EARLY_PHASE1":4556,"PHASE1":4558,"PHASE2":4560,"PHASE3":4562,"PHASE4":4564,"NA":4566},{"trials":4557,"activeCount":92},[],{"trials":4559,"activeCount":92},[],{"trials":4561,"activeCount":92},[],{"trials":4563,"activeCount":92},[],{"trials":4565,"activeCount":92},[],{"trials":4567,"activeCount":92},[4568],{"nctId":4541,"briefTitle":4542,"status":102,"phases":4569,"primaryCompletion":4544,"completion":4544,"start":4545,"enrollment":4546,"conditions":4570,"interventions":4571},[84],[4548,4549,4550,4551],[4526,4553],{"intervention":4573,"totalTrials":123,"cells":4574},"Bupivacaine",{"EARLY_PHASE1":4575,"PHASE1":4577,"PHASE2":4579,"PHASE3":4581,"PHASE4":4583,"NA":4585},{"trials":4576,"activeCount":92},[],{"trials":4578,"activeCount":92},[],{"trials":4580,"activeCount":92},[],{"trials":4582,"activeCount":92},[],{"trials":4584,"activeCount":92},[],{"trials":4586,"activeCount":92},[4587],{"nctId":4588,"briefTitle":4589,"status":102,"phases":4590,"primaryCompletion":4591,"completion":4591,"start":4592,"enrollment":4593,"conditions":4594,"interventions":4599},"NCT03834454","Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population",[84],"2013-12-31","2013-10-01",112,[4595,4596,4597,4598],"Cesarean Section","Hypotension Drug-Induced","Spinal Anesthesia","Postoperative Complications",[4573,4573],{"intervention":4601,"totalTrials":123,"cells":4602},"Bupivacaine 0,5%",{"EARLY_PHASE1":4603,"PHASE1":4605,"PHASE2":4607,"PHASE3":4609,"PHASE4":4611,"NA":4613},{"trials":4604,"activeCount":92},[],{"trials":4606,"activeCount":92},[],{"trials":4608,"activeCount":92},[],{"trials":4610,"activeCount":92},[],{"trials":4612,"activeCount":92},[],{"trials":4614,"activeCount":92},[4615],{"nctId":4616,"briefTitle":4617,"status":102,"phases":4618,"primaryCompletion":1981,"completion":1775,"start":2667,"enrollment":1683,"conditions":4619,"interventions":4621},"NCT03046719","Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal",[84],[4620],"Retinal Detachment",[4601,4622],"NaCl 0,9%",{"intervention":4622,"totalTrials":123,"cells":4624},{"EARLY_PHASE1":4625,"PHASE1":4627,"PHASE2":4629,"PHASE3":4631,"PHASE4":4633,"NA":4635},{"trials":4626,"activeCount":92},[],{"trials":4628,"activeCount":92},[],{"trials":4630,"activeCount":92},[],{"trials":4632,"activeCount":92},[],{"trials":4634,"activeCount":92},[],{"trials":4636,"activeCount":92},[4637],{"nctId":4616,"briefTitle":4617,"status":102,"phases":4638,"primaryCompletion":1981,"completion":1775,"start":2667,"enrollment":1683,"conditions":4639,"interventions":4640},[84],[4620],[4601,4622],{"intervention":4642,"totalTrials":123,"cells":4643},"Vapocoolant spray, EMLA",{"EARLY_PHASE1":4644,"PHASE1":4646,"PHASE2":4648,"PHASE3":4650,"PHASE4":4652,"NA":4654},{"trials":4645,"activeCount":92},[],{"trials":4647,"activeCount":92},[],{"trials":4649,"activeCount":92},[],{"trials":4651,"activeCount":92},[],{"trials":4653,"activeCount":92},[],{"trials":4655,"activeCount":92},[4656],{"nctId":4657,"briefTitle":4658,"status":102,"phases":4659,"primaryCompletion":4660,"completion":2210,"start":4661,"enrollment":4662,"conditions":4663,"interventions":4665},"NCT03134391","Comparison Between Vapocoolant Spray and Eutectic Mixture of Local Anesthetics in Reducing Pain From Spinal Injection",[84],"2016-10-30","2016-08-01",97,[4664],"Adult Patient Undergoing Elective Surgery With Spinal Anesthesia",[4642],{"intervention":4667,"totalTrials":123,"cells":4668},"acupuncture and standard care",{"EARLY_PHASE1":4669,"PHASE1":4671,"PHASE2":4673,"PHASE3":4675,"PHASE4":4677,"NA":4679},{"trials":4670,"activeCount":92},[],{"trials":4672,"activeCount":92},[],{"trials":4674,"activeCount":92},[],{"trials":4676,"activeCount":92},[],{"trials":4678,"activeCount":92},[],{"trials":4680,"activeCount":92},[4681],{"nctId":4682,"briefTitle":4683,"status":102,"phases":4684,"primaryCompletion":4685,"completion":4686,"start":2536,"enrollment":4182,"conditions":4687,"interventions":4689},"NCT04844710","The Effects of Acupuncture in Overcoming Inflammatory Response to COVID-19 Mild-moderate Symptoms",[84],"2020-11-15","2020-11-20",[4688,2425],"Acupuncture",[4667,4690],"standard care",{"intervention":4690,"totalTrials":123,"cells":4692},{"EARLY_PHASE1":4693,"PHASE1":4695,"PHASE2":4697,"PHASE3":4699,"PHASE4":4701,"NA":4703},{"trials":4694,"activeCount":92},[],{"trials":4696,"activeCount":92},[],{"trials":4698,"activeCount":92},[],{"trials":4700,"activeCount":92},[],{"trials":4702,"activeCount":92},[],{"trials":4704,"activeCount":92},[4705],{"nctId":4682,"briefTitle":4683,"status":102,"phases":4706,"primaryCompletion":4685,"completion":4686,"start":2536,"enrollment":4182,"conditions":4707,"interventions":4708},[84],[4688,2425],[4667,4690],{"intervention":4710,"totalTrials":123,"cells":4711},"Alpha-Tocopherol",{"EARLY_PHASE1":4712,"PHASE1":4714,"PHASE2":4716,"PHASE3":4718,"PHASE4":4720,"NA":4722},{"trials":4713,"activeCount":92},[],{"trials":4715,"activeCount":92},[],{"trials":4717,"activeCount":92},[],{"trials":4719,"activeCount":92},[],{"trials":4721,"activeCount":92},[],{"trials":4723,"activeCount":92},[4724],{"nctId":4725,"briefTitle":4726,"status":102,"phases":4727,"primaryCompletion":4728,"completion":4729,"start":4730,"enrollment":596,"conditions":4731,"interventions":4734},"NCT03948737","The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major",[84],"2017-07-30","2017-08-01","2016-12-30",[4732,4733,28],"Beta Thalassemia Major Anemia","Hemolysis",[4710],{"intervention":4736,"totalTrials":123,"cells":4737},"Hydroxychloroquine",{"EARLY_PHASE1":4738,"PHASE1":4740,"PHASE2":4742,"PHASE3":4744,"PHASE4":4746,"NA":4748},{"trials":4739,"activeCount":92},[],{"trials":4741,"activeCount":92},[],{"trials":4743,"activeCount":92},[],{"trials":4745,"activeCount":92},[],{"trials":4747,"activeCount":92},[],{"trials":4749,"activeCount":92},[4750],{"nctId":4751,"briefTitle":4752,"status":102,"phases":4753,"primaryCompletion":4754,"completion":4754,"start":4755,"enrollment":4756,"conditions":4757,"interventions":4759},"NCT03085940","Role of Hydroxychloroquine to Improve Endothelial Dysfunction in Patients With Rheumatoid Arthritis",[84],"2017-09-30","2017-01-20",37,[4758],"Rheumatoid Arthritis",[4736],{"intervention":4761,"totalTrials":123,"cells":4762},"Intracavernosal Injection of Umbilical Cord Mesenchymal Stem Cell Secretome",{"EARLY_PHASE1":4763,"PHASE1":4765,"PHASE2":4767,"PHASE3":4769,"PHASE4":4771,"NA":4773},{"trials":4764,"activeCount":92},[],{"trials":4766,"activeCount":92},[],{"trials":4768,"activeCount":92},[],{"trials":4770,"activeCount":92},[],{"trials":4772,"activeCount":92},[],{"trials":4774,"activeCount":92},[4775],{"nctId":4776,"briefTitle":4777,"status":102,"phases":4778,"primaryCompletion":4779,"completion":4779,"start":4780,"enrollment":2511,"conditions":4781,"interventions":4783},"NCT07245875","Umbilical Cord Mesenchymal Stem Cell Secretome Administration in Severe Erectile Dysfunction Non-responsive to Sildenafil",[84],"2025-08-01","2024-04-12",[4782,145],"Erectile Dysfunction",[4761],{"intervention":4785,"totalTrials":123,"cells":4786},"Benzydamine Hydrochloride 0.15% Oral Rinse",{"EARLY_PHASE1":4787,"PHASE1":4789,"PHASE2":4791,"PHASE3":4793,"PHASE4":4795,"NA":4797},{"trials":4788,"activeCount":92},[],{"trials":4790,"activeCount":92},[],{"trials":4792,"activeCount":92},[],{"trials":4794,"activeCount":92},[],{"trials":4796,"activeCount":92},[],{"trials":4798,"activeCount":92},[4799],{"nctId":4800,"briefTitle":4801,"status":102,"phases":4802,"primaryCompletion":1508,"completion":4803,"start":4804,"enrollment":940,"conditions":4805,"interventions":4807},"NCT04167592","Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP",[84],"2018-10-01","2018-08-01",[4806],"ERCP",[4785,4808],"Water",{"intervention":4808,"totalTrials":123,"cells":4810},{"EARLY_PHASE1":4811,"PHASE1":4813,"PHASE2":4815,"PHASE3":4817,"PHASE4":4819,"NA":4821},{"trials":4812,"activeCount":92},[],{"trials":4814,"activeCount":92},[],{"trials":4816,"activeCount":92},[],{"trials":4818,"activeCount":92},[],{"trials":4820,"activeCount":92},[],{"trials":4822,"activeCount":92},[4823],{"nctId":4800,"briefTitle":4801,"status":102,"phases":4824,"primaryCompletion":1508,"completion":4803,"start":4804,"enrollment":940,"conditions":4825,"interventions":4826},[84],[4806],[4785,4808],{"intervention":4828,"totalTrials":123,"cells":4829},"Combined Spinal anesthesia (heavy bupivacaine 0.5%) and General anesthesia",{"EARLY_PHASE1":4830,"PHASE1":4832,"PHASE2":4834,"PHASE3":4836,"PHASE4":4838,"NA":4840},{"trials":4831,"activeCount":92},[],{"trials":4833,"activeCount":92},[],{"trials":4835,"activeCount":92},[],{"trials":4837,"activeCount":92},[],{"trials":4839,"activeCount":92},[],{"trials":4841,"activeCount":92},[4842],{"nctId":4843,"briefTitle":4844,"status":102,"phases":4845,"primaryCompletion":471,"completion":471,"start":4846,"enrollment":1683,"conditions":4847,"interventions":4850},"NCT06892600","Combined General and Spinal Anesthesia Compared to General Anesthesia During Laparoscopic Surgery : a Randomised Controlled Trial",[84],"2023-08-03",[4848,4597,4849],"Laparoscopic Abdominal Surgery","General Anesthesia Using Endotracheal Intubation",[4828,3196],{"intervention":3196,"totalTrials":123,"cells":4852},{"EARLY_PHASE1":4853,"PHASE1":4855,"PHASE2":4857,"PHASE3":4859,"PHASE4":4861,"NA":4863},{"trials":4854,"activeCount":92},[],{"trials":4856,"activeCount":92},[],{"trials":4858,"activeCount":92},[],{"trials":4860,"activeCount":92},[],{"trials":4862,"activeCount":92},[],{"trials":4864,"activeCount":92},[4865],{"nctId":4843,"briefTitle":4844,"status":102,"phases":4866,"primaryCompletion":471,"completion":471,"start":4846,"enrollment":1683,"conditions":4867,"interventions":4868},[84],[4848,4597,4849],[4828,3196],{"intervention":4870,"totalTrials":123,"cells":4871},"Dexmedetomidine 3 mcg",{"EARLY_PHASE1":4872,"PHASE1":4874,"PHASE2":4876,"PHASE3":4878,"PHASE4":4880,"NA":4882},{"trials":4873,"activeCount":92},[],{"trials":4875,"activeCount":92},[],{"trials":4877,"activeCount":92},[],{"trials":4879,"activeCount":92},[],{"trials":4881,"activeCount":92},[],{"trials":4883,"activeCount":92},[4884],{"nctId":4885,"briefTitle":4886,"status":102,"phases":4887,"primaryCompletion":4888,"completion":4888,"start":4889,"enrollment":596,"conditions":4890,"interventions":4894},"NCT07144215","ED50 of Dexmedetomidine as an Adjuvant to 0.5% Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Hip and Knee Surgery: An Up-and-Down Method Approach",[84],"2025-05-31","2025-02-01",[4891,4892,4893],"Knee Surgery","Pelvic Surgery","Spinal Aneshtesia",[4870,4895,4896,4897,4898],"Dexmedetomidine 4 mcg","Dexmedetomidine 5 mcg","Dexmedetomidine 6 mcg","Bupivacain hyperbaric 0.5% 12.5 mg",{"intervention":4895,"totalTrials":123,"cells":4900},{"EARLY_PHASE1":4901,"PHASE1":4903,"PHASE2":4905,"PHASE3":4907,"PHASE4":4909,"NA":4911},{"trials":4902,"activeCount":92},[],{"trials":4904,"activeCount":92},[],{"trials":4906,"activeCount":92},[],{"trials":4908,"activeCount":92},[],{"trials":4910,"activeCount":92},[],{"trials":4912,"activeCount":92},[4913],{"nctId":4885,"briefTitle":4886,"status":102,"phases":4914,"primaryCompletion":4888,"completion":4888,"start":4889,"enrollment":596,"conditions":4915,"interventions":4916},[84],[4891,4892,4893],[4870,4895,4896,4897,4898],{"intervention":4896,"totalTrials":123,"cells":4918},{"EARLY_PHASE1":4919,"PHASE1":4921,"PHASE2":4923,"PHASE3":4925,"PHASE4":4927,"NA":4929},{"trials":4920,"activeCount":92},[],{"trials":4922,"activeCount":92},[],{"trials":4924,"activeCount":92},[],{"trials":4926,"activeCount":92},[],{"trials":4928,"activeCount":92},[],{"trials":4930,"activeCount":92},[4931],{"nctId":4885,"briefTitle":4886,"status":102,"phases":4932,"primaryCompletion":4888,"completion":4888,"start":4889,"enrollment":596,"conditions":4933,"interventions":4934},[84],[4891,4892,4893],[4870,4895,4896,4897,4898],{"intervention":4897,"totalTrials":123,"cells":4936},{"EARLY_PHASE1":4937,"PHASE1":4939,"PHASE2":4941,"PHASE3":4943,"PHASE4":4945,"NA":4947},{"trials":4938,"activeCount":92},[],{"trials":4940,"activeCount":92},[],{"trials":4942,"activeCount":92},[],{"trials":4944,"activeCount":92},[],{"trials":4946,"activeCount":92},[],{"trials":4948,"activeCount":92},[4949],{"nctId":4885,"briefTitle":4886,"status":102,"phases":4950,"primaryCompletion":4888,"completion":4888,"start":4889,"enrollment":596,"conditions":4951,"interventions":4952},[84],[4891,4892,4893],[4870,4895,4896,4897,4898],{"intervention":4898,"totalTrials":123,"cells":4954},{"EARLY_PHASE1":4955,"PHASE1":4957,"PHASE2":4959,"PHASE3":4961,"PHASE4":4963,"NA":4965},{"trials":4956,"activeCount":92},[],{"trials":4958,"activeCount":92},[],{"trials":4960,"activeCount":92},[],{"trials":4962,"activeCount":92},[],{"trials":4964,"activeCount":92},[],{"trials":4966,"activeCount":92},[4967],{"nctId":4885,"briefTitle":4886,"status":102,"phases":4968,"primaryCompletion":4888,"completion":4888,"start":4889,"enrollment":596,"conditions":4969,"interventions":4970},[84],[4891,4892,4893],[4870,4895,4896,4897,4898],{"intervention":4972,"totalTrials":123,"cells":4973},"85% TCA Solution",{"EARLY_PHASE1":4974,"PHASE1":4976,"PHASE2":4978,"PHASE3":4980,"PHASE4":4982,"NA":4984},{"trials":4975,"activeCount":92},[],{"trials":4977,"activeCount":92},[],{"trials":4979,"activeCount":92},[],{"trials":4981,"activeCount":92},[],{"trials":4983,"activeCount":92},[],{"trials":4985,"activeCount":92},[4986],{"nctId":4987,"briefTitle":4988,"status":102,"phases":4989,"primaryCompletion":4990,"completion":4990,"start":4991,"enrollment":596,"conditions":4992,"interventions":4994},"NCT04911075","Depth of Necrosis in Normal Cervical Epithelium After 85% Trichloroacetic Acid (TCA) Application",[84],"2021-10-25","2021-04-15",[4993],"Cervix; Intraepithelial Neoplasia",[4972],{"intervention":4996,"totalTrials":123,"cells":4997},"Midazolam",{"EARLY_PHASE1":4998,"PHASE1":5000,"PHASE2":5002,"PHASE3":5004,"PHASE4":5006,"NA":5008},{"trials":4999,"activeCount":92},[],{"trials":5001,"activeCount":92},[],{"trials":5003,"activeCount":92},[],{"trials":5005,"activeCount":92},[],{"trials":5007,"activeCount":92},[],{"trials":5009,"activeCount":92},[5010],{"nctId":5011,"briefTitle":5012,"status":102,"phases":5013,"primaryCompletion":4408,"completion":3853,"start":5014,"enrollment":182,"conditions":5015,"interventions":5017},"NCT03269929","Comparison Between Efficacy of Music Therapy and Intravenous Midazolam 0.02 mg\u002FkgBW in Reducing Preoperative Anxiety",[84],"2017-01-01",[5016],"Cancer",[4996],{"intervention":3889,"totalTrials":123,"cells":5019},{"EARLY_PHASE1":5020,"PHASE1":5022,"PHASE2":5024,"PHASE3":5026,"PHASE4":5028,"NA":5030},{"trials":5021,"activeCount":92},[],{"trials":5023,"activeCount":92},[],{"trials":5025,"activeCount":92},[],{"trials":5027,"activeCount":92},[],{"trials":5029,"activeCount":92},[],{"trials":5031,"activeCount":92},[5032],{"nctId":3882,"briefTitle":3883,"status":102,"phases":5033,"primaryCompletion":3885,"completion":3885,"start":3886,"enrollment":281,"conditions":5034,"interventions":5035},[84],[283],[3859,3889],{"intervention":5037,"totalTrials":123,"cells":5038},"lidocaine inhalation; intravenous dexamethasone",{"EARLY_PHASE1":5039,"PHASE1":5041,"PHASE2":5043,"PHASE3":5045,"PHASE4":5047,"NA":5049},{"trials":5040,"activeCount":92},[],{"trials":5042,"activeCount":92},[],{"trials":5044,"activeCount":92},[],{"trials":5046,"activeCount":92},[],{"trials":5048,"activeCount":92},[],{"trials":5050,"activeCount":92},[5051],{"nctId":5052,"briefTitle":5053,"status":102,"phases":5054,"primaryCompletion":5055,"completion":2210,"start":5056,"enrollment":5057,"conditions":5058,"interventions":5060},"NCT03139591","Comparison Between Lidocaine Inhalation and Intravenous Dexamethasone in Reducing Pain After Laryngeal Mask Insertion",[84],"2017-01-31","2016-11-01",196,[5059],"Adult Patients Undergoing Elective Surgery With General Anesthesia and LMA Insertion",[5037],{"intervention":5062,"totalTrials":123,"cells":5063},"Fenofibrate",{"EARLY_PHASE1":5064,"PHASE1":5066,"PHASE2":5068,"PHASE3":5070,"PHASE4":5072,"NA":5074},{"trials":5065,"activeCount":92},[],{"trials":5067,"activeCount":92},[],{"trials":5069,"activeCount":92},[],{"trials":5071,"activeCount":92},[],{"trials":5073,"activeCount":92},[],{"trials":5075,"activeCount":92},[5076],{"nctId":5077,"briefTitle":5078,"status":102,"phases":5079,"primaryCompletion":3853,"completion":3853,"start":5056,"enrollment":719,"conditions":5080,"interventions":5082},"NCT04885153","Effects of Oral Fenofibrate on Retinal Thickness and Macular Volume",[84],[791,5081,32],"Dyslipidemias",[5062],{"intervention":5084,"totalTrials":123,"cells":5085},"vitamin C, vitamin B1",{"EARLY_PHASE1":5086,"PHASE1":5088,"PHASE2":5090,"PHASE3":5092,"PHASE4":5094,"NA":5096},{"trials":5087,"activeCount":92},[],{"trials":5089,"activeCount":92},[],{"trials":5091,"activeCount":92},[],{"trials":5093,"activeCount":92},[],{"trials":5095,"activeCount":92},[],{"trials":5097,"activeCount":92},[5098],{"nctId":5099,"briefTitle":5100,"status":102,"phases":5101,"primaryCompletion":938,"completion":938,"start":5102,"enrollment":5103,"conditions":5104,"interventions":5105},"NCT04137276","Effect of Intravenous Vitamin C on SOFA Score Among Septic Patients",[84],"2019-04-01",33,[18],[5084,5106],"vitamin B1",{"intervention":5106,"totalTrials":123,"cells":5108},{"EARLY_PHASE1":5109,"PHASE1":5111,"PHASE2":5113,"PHASE3":5115,"PHASE4":5117,"NA":5119},{"trials":5110,"activeCount":92},[],{"trials":5112,"activeCount":92},[],{"trials":5114,"activeCount":92},[],{"trials":5116,"activeCount":92},[],{"trials":5118,"activeCount":92},[],{"trials":5120,"activeCount":92},[5121],{"nctId":5099,"briefTitle":5100,"status":102,"phases":5122,"primaryCompletion":938,"completion":938,"start":5102,"enrollment":5103,"conditions":5123,"interventions":5124},[84],[18],[5084,5106]]